US6562067B2 - Stent with interlocking elements - Google Patents

Stent with interlocking elements Download PDF

Info

Publication number
US6562067B2
US6562067B2 US09/877,506 US87750601A US6562067B2 US 6562067 B2 US6562067 B2 US 6562067B2 US 87750601 A US87750601 A US 87750601A US 6562067 B2 US6562067 B2 US 6562067B2
Authority
US
United States
Prior art keywords
stent
projection
stent according
adjacent
lateral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime, expires
Application number
US09/877,506
Other versions
US20020188347A1 (en
Inventor
Mark Mathis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardinal Health Switzerland 515 GmbH
Original Assignee
Cordis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cordis Corp filed Critical Cordis Corp
Priority to US09/877,672 priority Critical patent/US6599314B2/en
Priority to US09/877,506 priority patent/US6562067B2/en
Assigned to CORDIS CORPORATION reassignment CORDIS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MATHIS, MARK
Priority to IL14964602A priority patent/IL149646A0/en
Priority to AU40658/02A priority patent/AU782122C/en
Priority to AT02253789T priority patent/ATE306874T1/en
Priority to ES02253789T priority patent/ES2250587T3/en
Priority to DE60206694T priority patent/DE60206694T2/en
Priority to DK02253789T priority patent/DK1266638T3/en
Priority to EP02253789A priority patent/EP1266638B1/en
Priority to CA002389401A priority patent/CA2389401C/en
Priority to KR1020020031823A priority patent/KR100855889B1/en
Priority to JP2002167691A priority patent/JP4233810B2/en
Publication of US20020188347A1 publication Critical patent/US20020188347A1/en
Publication of US6562067B2 publication Critical patent/US6562067B2/en
Application granted granted Critical
Assigned to CARDINAL HEALTH SWITZERLAND 515 GmbH reassignment CARDINAL HEALTH SWITZERLAND 515 GmbH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CORDIS CORPORATION
Adjusted expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91591Locking connectors, e.g. using male-female connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped

Definitions

  • the present invention relates, in general, to intraluminal medical devices, and, more particularly, two a new and useful stent, stent delivery apparatus and method for stenting a vessel using a stent with interlocking elements.
  • a stent is commonly used as a tubular structure left inside the lumen of a duct to relieve an obstruction.
  • stents are inserted into the lumen in a non-expanded form and are then expanded autonomously (or with the aid of a second device) in situ.
  • stents are placed percutaneously through the femoral artery. In this type of procedure, stents are delivered on a catheter and are either self-expanding or, in the majority of cases, expanded by a balloon. Self-explanding stents do not need a balloon to be deployed.
  • the stents are constructed using metals with spring-like or superelastic properties (i.e., Nitinol), which inherently exhibit constant radial support.
  • Self-expanding stents are also often used in vessels close to the skin (i.e., carotid arteries) or vessels that can experience a lot of movement (i.e., popliteal artery). Due to a natural elastic recoil, self-expanding stents withstand pressure or shifting and maintain their shape.
  • the typical method of expansion for balloon expanded stents occurs through the use of a catheter mounted angioplasty balloon, which is inflated within the stenosed vessel or body passageway, in order to shear and disrupt the obstructions associated with the wall components of the vessel and to obtain an enlarged lumen.
  • Balloon-expandable stents involve crimping the device onto an angioplasty balloon.
  • the stent takes shape as the balloon is inflated and remains in place when the balloon and delivery system are deflated and removed.
  • balloon-expandable stents are available either pre-mounted or unmounted.
  • a pre-mounted system has the stent already crimped on a balloon, while an unmounted system gives the physician the option as to what combination of devices (catheters and stents) to use.
  • the stent is first introduced into the blood vessel on a balloon catheter. Then, the balloon is inflated causing the stent to expand and press against the vessel wall. After expanding the stent, the balloon is deflated and withdrawn from the vessel together with the catheter. Once the balloon is withdrawn, the stent stays in place permanently, holding the vessel open and improving the flow of blood.
  • the present invention relates to an apparatus and method for stenting a vessel in conjunction with a particular new and useful stent having a lattice of interconnecting elements defining a substantially cylindrical configuration.
  • the lattice has a first open end and a second open end wherein the lattice is movable between a locked configuration and an open configuration.
  • One embodiment of the stent includes a plurality of bridges connecting the interconnecting elements wherein each bridge interlocks with an adjacent bridge in the locked configuration and wherein each bridge separates from the adjacent bridge in the open configuration.
  • the interlocking elements include a plurality of struts wherein each strut interlocks with an adjacent strut in the locked configuration and each strut separates from the adjacent strut in the open configuration.
  • each bridge has a projection and a base wherein the base has a projection holding section for receiving the projection from an adjacent bridge.
  • each strut has a projection and a base wherein the base has a projection holding section for receiving the projection from an adjacent strut.
  • the interlocking elements comprise a plurality of adjacent sections.
  • the adjacent sections comprise adjacent hoops wherein each hoop comprises a plurality of loops. Each loop comprises at least one strut.
  • lateral arms extend from the base.
  • the projection holding section of the base has an opening therein for receiving the projection.
  • An extension is connected between the base and the projection, and, for the interlocking bridge embodiment, the extension includes a neck wherein the projection is located at a superior position on the neck.
  • the projection also includes at least one lateral lip and the projection holding section includes at least one lateral ledge for releasably engaging the at least one lateral lip of the projection.
  • the projection also includes at least one sidewall adjacent to the at least one lateral lip.
  • the projection holding section includes at least one lateral depression adjacent to the at least one lateral ledge for releasably engaging the at least one sidewall of the projection.
  • the at least one sidewall is curved and the at least one depression is curved wherein these elements are aligned, snapped-fit or interlock in a puzzle-lock manner.
  • the lateral arms of the base connect directly to the interconnecting elements of the lattice.
  • the stent of the present invention is directed toward both a balloon actuated stent and a self-expanding stent.
  • the stent is made of any suitable material.
  • the stent is made of an alloy such as stainless steel.
  • the stent is made of a nickel titanium (Nitinol) alloy.
  • this material or any other super-elastic alloy is suitable for the stent according to the present invention.
  • the stent is a crush recoverable stent.
  • the present invention is also directed toward an apparatus and method for stenting a vessel utilizing the stent embodiments described above, e.g., a stent having a lattice of interconnecting elements and including interlocking features such as a plurality of interlocking bridges in one embodiment or a plurality of interlocking struts in another embodiment.
  • the apparatus further includes a catheter having an inner sleeve and an expandable member on the inner sleeve wherein the expandable member is movable between a collapsed state and an expanded state.
  • a catheter having an inner sleeve and an expandable member on the inner sleeve wherein the expandable member is movable between a collapsed state and an expanded state.
  • One of the stent embodiments described above is secured to the catheter over the expandable member when the expandable member is in the collapsed state and the stent is in the locked configuration.
  • the stent is separated or deployed from the catheter when the expandable member is in the expanded state and the stent is in the open configuration.
  • the apparatus further includes a cover movably disposed over the stent.
  • the cover is an outer sheath made of a polymer material.
  • the expandable member is an inflatable balloon.
  • the method for stenting a vessel according to the present invention comprises the steps of providing the apparatus according to the present invention have one of the stent embodiments, e.g., the interlocking bridge embodiment or the interlocking strut embodiment, and inserting the apparatus within a vessel.
  • the distal end of the apparatus is positioned at a desired location within the vessel and the stent is deployed to the open configuration with the expandable member.
  • the method further includes providing the cover movably disposed over the stent for preventing the stent from moving to the open configuration until desired.
  • the method further comprises deploying the stent to the open configuration by inflation of the expandable member.
  • the method further comprises securing the stent to the catheter by interlocking the bridges (for the interlocking bridge embodiment) or by interlocking the struts (for the interlocking strut embodiment) prior to performing certain steps according to the present invention.
  • the method according to the present invention also comprises removing the catheter from the patient after the deployment of the stent.
  • FIG. 1A is a perspective view of a first embodiment of a stent in a closed configuration in accordance with the present invention
  • FIG. 1B is a perspective view of a second embodiment of a stent in a closed configuration in accordance with the present invention
  • FIG. 2A is a partial side plan view of an interlocking bridge for the stent of FIG. 1A;
  • FIG. 2B is a partial side plan view of an interlocking strut for the stent of FIG. 1B;
  • FIG. 3A is a partial side view of the lattice of the stent of FIG. 1A;
  • FIG. 3B is a partial side view of the lattice of the stent of FIG. 1B;
  • FIG. 4A is a partial perspective view of the stent of FIG. 1A in an open configuration
  • FIG. 4B is a partial perspective view of the stent of FIG. 1B in an open configuration
  • FIG. 5A is a partial perspective view of a distal end of an apparatus according to the present invention utilizing the stent of FIG. 1A;
  • FIG. 5B is a partial perspective view of a distal end of an apparatus according to the present invention utilizing the stent of FIG. 1 B.
  • a stent 100 that is an expandable prosthesis for a body passageway is illustrated.
  • the terms “stent” and “prosthesis” are interchangeably used to some extent in describing the present invention, insofar as the method, apparatus, and structures of the present invention may be utilized not only in connection with an expandable intraluminal vascular graft for expanding partially occluded segments of a blood vessel, duct or body passageways, such as within an organ, but may so be utilized for many other purposes as an expandable prosthesis for many other types of body passageways.
  • expandable prostheses may also be used for such purposes as: (1) supportive graft placement within blocked arteries opened by transluminal recanalization, but which are likely to collapse in the absence of internal support; (2) similar use following catheter passage through mediastinal and other veins occluded by inoperable cancers; (3) reinforcement of catheter created intrahepatic communications between portal and hepatic veins in patients suffering from portal hypertension; (4) supportive graft placement of narrowing of the esophagus, the intestine, the ureters, the uretha, etc.; (5) intraluminally bypassing a defect such as an aneurysm or blockage within a vessel or organ; and (6) supportive graft reinforcement of reopened and previously obstructed bile ducts.
  • body passageway encompasses any lumen or duct within the human body, such as those previously described, as well as any vein, artery, or blood vessel within the human vascular system.
  • the stent 100 is an expandable lattice structure made of any suitable material which is compatible with the human body and the bodily fluids (not shown) with which the stent 100 may come into contact.
  • the lattice structure is an arrangement of interconnecting elements made of a material which has the requisite strength and elasticity characteristics to permit the tubular shaped stent 100 to be expanded from the closed configuration shown in FIGS. 1A and 1B to the expanded configuration shown in FIGS. 4A and 4B and further to permit the stent 100 to retain its expanded configuration at the enlarged diameter d 1 .
  • Suitable materials for the fabrication of the stent 100 include silver, tantalum, stainless steel, gold, titanium or any suitable plastic material having the requisite characteristics previously described.
  • the stent is fabricated from 316L stainless steel alloy
  • the stent 100 comprises a superelastic alloy such as nickel titanium (NiTi, e.g., Nitinol). More preferably, the stent 100 is formed from an alloy comprising from about 50.5 to 60.0% Ni by atomic weight and the remainder Ti. Even more preferably, the stent 100 is formed from an alloy comprising about 55% Ni and about 45% Ti.
  • the stent 100 is preferably designed such that it is superelastic at body temperature, and preferably has an Af temperature in the range from about 24° C. to about 37° C. The superelastic design of the stent 100 makes it crush recoverable and thus suitable as a stent or frame for any number of vascular devices for different applications.
  • the stent 100 comprises a tubular configuration formed by a lattice of interconnecting elements defining a substantially cylindrical configuration and having front and back open ends 102 , 104 and defining a longitudinal axis 103 extending therebetween.
  • the stent 100 In its closed configuration, the stent 100 has a first diameter (d 1 ) for insertion into a patient and navigation through the vessels and, in its open configuration, a second diameter (d 2 ), as shown in FIGS. 4A and 4B, for deployment into the target area of a vessel with the second diameter being greater than the first diameter.
  • the stent 100 comprises a plurality of adjacent hoops 106 ( a )-( d ) extending between the front and back ends 102 , 104 .
  • the hoops 106 ( a )-( d ) include a plurality of longitudinally arranged struts 108 and a plurality of loops 110 connecting adjacent struts 108 . Adjacent struts 108 are connected at opposite ends so as to form a substantially S or Z shape pattern.
  • the plurality of loops 110 have a substantially semi-circular configuration and are substantially symmetric about their centers.
  • the stent 100 further comprises a plurality of bridges 114 , which connect adjacent hoops 106 ( a )-( d ).
  • the details of the bridges 114 are more fully illustrated in FIGS. 2A, and 3 A and described below.
  • Each bridge comprises two ends wherein one end of each bridge 114 is attached to one loop 110 on one hoop 106 ( a ) and the other end of each bridge 114 is attached to one loop 110 on an adjacent hoop 106 ( b ).
  • the bridges 114 connect adjacent hoops 106 ( a )-( d ) together at bridge to loop connection regions 120 , 122 as shown in FIG. 2 A.
  • the above-described geometry better distributes strain throughout the stent 100 , prevents metal to metal contact where the stent 100 is bent, and minimizes the opening between the features of the stent 100 ; namely, struts 108 , loops 110 and bridges 114 .
  • the number of and nature of the design of the struts, loops and bridges are important design factors when determining the working properties and fatigue life properties of the stent 100 . It was previously thought that in order to improve the rigidity of the stent, struts should be large, and thus there should be fewer struts 108 per hoop 106 ( a )-( d ).
  • each hoop 106 ( a )-( d ) has between twenty-four (24) to thirty-six (36) or more struts 108. It has been determined that a stent having a ratio of number of struts per hoop to strut length which is greater than four hundred has increased rigidity over prior art stents which typically have a ratio of under two hundred. The length of a strut is measured in its compressed state parallel to the longitudinal axis 103 of the stent 100 as illustrated in FIG. 1 A.
  • FIG. 4A illustrates the stent 100 in its open or expanded state.
  • the geometry of the stent 100 changes quite significantly as it is deployed from its unexpanded state (closed or locked configuration) to its expanded state (open or unlocked configuration).
  • the strut angle and strain levels in the loops 110 and bridges 114 are affected.
  • all of the stent features will strain in a predictable manner so that the stent 100 is reliable and uniform in strength.
  • Nitinol properties are more generally limited by strain rather than by stress.
  • the embodiments illustrated in FIGS. 1A-5B has a design to help minimize forces such as strain.
  • FIG. 1A illustrates the first embodiment of the stent 100 according to the present invention including a plurality of interlocking bridges 114 connecting adjacent hoops 106 ( a )-( d ).
  • stent 100 has bridges 114 wherein each bridge 114 includes a base 126 .
  • the base 126 has a pair of laterally extending arms 128 wherein each end of the lateral arms 128 are connected directly to a loop 110 at loop connection regions 120 and 122 .
  • one laterally extending arm connects to one of the adjacent hoops 106 ( a )-( d ) at the loop connection region 120 of one loop 110 and the other lateral extending arm 128 of the bridge 114 is connected to an adjacent loop 110 at the loop connection region 122 .
  • the bridge 114 alternatively connects adjacent hoops 106 ( a )-( d ).
  • the bridge 114 further includes an extension 130 extending in a superior direction from the base 126 .
  • the extension 130 includes a neck 131 at the superior end of the extension 130 .
  • a projection 132 is fixed to the superior end of the neck 131 of the extension 130 .
  • the projection 132 can comprise any desired configuration, one preferred configuration for the projection 132 includes a pair of lateral lips 134 laterally extending from the neck 131 and a pair of lateral sidewalls 136 extending from the lateral lips 134 respectively.
  • the lateral sidewalls 136 have a curved-shape.
  • the projection 132 further includes an upper edge 137 extending between the lateral sidewalls 136 .
  • the bridge 114 further includes a projection holding section 140 inferior to the extension 130 at the base 126 .
  • the projection holding section 140 is defined by an opening 142 in the base 126 .
  • the projection holding section 140 further includes a pair of lateral ledges 144 extending from each side of the opening 142 .
  • the projection holding section 140 further includes a lateral depression 146 extending from each lateral ledge 144 .
  • Each lateral depression 146 also has a curved-shape for this embodiment.
  • the projection holding section 140 includes an upper edge 147 extending between each lateral depression 146 .
  • the projection holding section 140 is shaped to fit and receive in a snap-fit or puzzle-lock manner the projection 132 of an adjacent bridge 114 . Due to the unique configuration of the bridge 114 , the projection 132 of a first bridge 114 is interlocked with the projection holding section 140 of a second bridge 114 .
  • the interlocking of bridges 114 is accomplished by insertion of the projection 132 of the first bridge 114 into the central opening 142 of the projection holding section 140 of the second bridge 114 such that the lateral lips 134 releasably engage the lateral ledges 144 of the projection holding section 140 .
  • the lateral sidewalls 136 of the projection 132 mates, in a releasable fashion, with the lateral depressions 146 of the projection holding section 140 of the second bridge 114 .
  • the upper edge 137 of the projection 132 of the first bridge 114 releasably mates with the upper edge 147 of the projection holding section 140 of the second bridge 114 . Accordingly, this arrangement insures for an interlocking of the first and second bridges 114 , e.g., adjacent bridges 114 , in a puzzle-like manner.
  • This arrangement of interlocking bridges 114 is clearly illustrated in FIG. 3 A. When deployed to an open configuration, the stent 100 for the interlocking bridge embodiment described above expands to a width D 2 as shown in FIG. 4 A.
  • FIG. 1 B A second embodiment for the stent 100 is shown in FIG. 1 B and includes a plurality of interlocking struts 108 a .
  • adjacent hoops 106 ( a )-( d ) are connected to each other by nonlocking bridges 114 a.
  • a plurality of interlocking struts 108 a are utilized in order to interlock by releasable engagement a first strut 108 a with a second strut 108 a as best shown in FIG. 3 B.
  • each interlocking strut 108 a includes base 126 and laterally extending sidearms 128 as shown in FIG. 2 B.
  • the strut 108 a further includes extension 130 extending in a superior direction from the base 126 .
  • Projection 132 is fixed to the superior end of the extension 130 .
  • the projection 132 can comprise any desired configuration, one preferred configuration for the projection 132 includes a pair of lateral lips 134 laterally extending from the extension 130 and a pair of lateral sidewalls 136 extending from the lateral lips 134 respectively.
  • the lateral sidewalls 136 have a curved-shape.
  • the projection 132 further includes upper edge 137 extending between the sidewalls 136 .
  • the strut 108 a (of the interlocking strut embodiment) further includes projection holding section 140 inferior to the extension 130 at the base 126 .
  • the projection holding section 140 is defined by opening 142 in the base 126 .
  • the projection holding section 140 further includes a pair of lateral ledges 144 extending from each side of the opening 142 .
  • the projection holding section 140 further includes lateral depression 146 extending from each lateral ledge 144 .
  • Each lateral depression 146 also has a curved-shape for this embodiment.
  • the projection holding section 140 includes upper edge 147 extending between each lateral depression 146 .
  • the projection holding section 140 is shaped to fit and receive in a snap-fit or puzzle-lock manner the projection 132 of an adjacent strut 108 a . Due to the unique configuration of the strut 108 a , the projection 132 of a first strut 108 a is interlocked with the projection holding section 140 of a second strut 108 a .
  • the interlocking of struts 108 a is accomplished by insertion of the projection 132 of the first strut 108 a into the central opening 142 of the projection holding section 140 of the second strut 108 a such that the lateral lips 134 releasably engage the lateral ledges 144 of the projection holding section 140 . Moreover, the lateral sidewalls 136 of the projection 132 mates, in a releasable fashion, with the lateral depressions 146 of the projection holding section 140 of the second strut 108 a .
  • the upper edge 137 of the projection 132 of the first strut 108 a releasably mates with the upper edge 147 of the projection holding section 140 of the second strut 108 a . Accordingly, this arrangement insures for an interlocking of the first and second struts 108 a , e.g., adjacent struts 108 a , in a puzzle-like manner.
  • This arrangement of interlocking struts 108 a is clearly illustrated in FIG. 3 B.
  • the first strut 108 a releasably engages with or interlocks with the second strut 108 a in a puzzle-lock manner.
  • the stent 100 having the interlocking struts 108 a (the inerlocking strut embodiment) is deployed or expanded to an open configuration having a width D 2 .
  • the stent 100 according to the present invention for both the interlocking bridge 114 embodiment and the interlocking strut 108 a embodiment is directed toward both deployment or expansion through an expandable member such as a balloon (to be described in greater detail below) and a self-expanding stent, i.e., a stent that is crush recoverable.
  • an expandable member such as a balloon (to be described in greater detail below) and a self-expanding stent, i.e., a stent that is crush recoverable.
  • the present invention also includes an apparatus and method for stenting a vessel utilizing the stent 100 (both the interlocking bridge 114 embodiment and the interlocking strut 108 a embodiment).
  • the stenting apparatus according to the present invention is generally designated 200 as best shown in FIGS. 5A and 5B.
  • FIG. 5A illustrates the apparatus 200 (as a catheter) which includes the stent 100 (the interlock bridge 114 embodiment)
  • FIG. 5B illustrates the apparatus 200 including the second embodiment for the stent 100 (the interlocking strut 108 a embodiment).
  • the catheter 200 has a distal end 210 culminating in a distal tip 215 .
  • the catheter 200 includes an inner sleeve 220 extending to the distal tip 215 .
  • An expandable member 230 such as an inflatable balloon, is fixed to the inner sleeve 220 at the distal end 210 of the catheter 200 .
  • the expandable member 230 is expanded, such as through inflation with a hydraulic or pneumatic fluid, and is expandable from a collapsed or closed configuration to an open or expanded configuration.
  • the stent 100 (both embodiments of FIGS. 1A and 1B) according to the present invention are secured to the distal end of the catheter 200 by closing the stent 100 over the expandable member 230 and the inner sleeve 220 as best illustrated in FIGS. 5A and 5B.
  • the stent 100 is secured to the catheter 200 by closing the stent 100 respectively by moving the stent 100 and to its locked configuration.
  • the locked configuration for the stent 100 includes interlocking the bridges 114 (for the interlocking bridge embodiment FIG. 5A) and for interlocking the struts 108 a (for the intrelocking strut embodiment FIG. 5B) in the respective manner described above.
  • the bridges 114 are moved and interlocked (as shown in FIG. 3A) such that the stent 100 is locked and in its closed configuration over the expandable member 230 .
  • the struts 108 a are moved and interlocked (as shown in FIG. 3B) such that the stent 100 is locked and in its closed configuration over the expandable member 230 .
  • the stent 100 is thereby secured to the catheter 200 until deployment is desired.
  • An outer sheath 240 which is made of a polymer material such as polyethylene, is used as a cover for the catheter distal end 210 and serves as an additional form of protection for securing of the stent 100 (both embodiments) to the catheter distal end 210 .
  • the cover 240 is movably positioned or movably disposed from the catheter distal end 210 in order to provide both the protection as described above as well as the unimpeded deployment of the stent 100 upon positioning of the stent 100 at its desired location.
  • the method of utilizing the catheter 200 includes first identifying a location in a patient's body for deployment of the stent 100 .
  • the catheter 200 is inserted within a vessel in the patient's body.
  • the catheter 200 is used to traverse the vessel until reaching the desired location wherein the distal end 210 of the catheter 200 is positioned at the desired location within the vessel.
  • the stent 100 is deployed to its open configuration by expanding the expandable member 230 such as by inflation. If the cover 240 is utilized to further protect and secure the stent 100 to the catheter distal end 210 , the cover 240 is removed from the distal end 210 prior to expansion of the expandable member 230 .
  • the expandable member 230 Upon expanding the stent 100 to its open configuration, the expandable member 230 is then collapsed, for instance through deflation of the expandable member, whereby the catheter 200 is removed from the deployment site of the vessel and patient's body altogether.

Abstract

A stent comprises a lattice of interconnecting elements defining a substantially cylindrical configuration having a first open end and a second open end. The lattice has a locked configuration and an open configuration. The stent also comprises a plurality of bridges connecting the interconnecting elements wherein each bridge interlocks with an adjacent bridge in the locked configuration and each bridge separates from the adjacent bridge in the open configuration. A second embodiment for the stent also comprises a lattice of interconnecting elements including a plurality of struts wherein each strut interlocks with an adjacent strut in the locked configuration and each strut separates from the adjacent strut in the open configuration.

Description

FIELD OF THE INVENTION
The present invention relates, in general, to intraluminal medical devices, and, more particularly, two a new and useful stent, stent delivery apparatus and method for stenting a vessel using a stent with interlocking elements.
BACKGROUND ART
A stent is commonly used as a tubular structure left inside the lumen of a duct to relieve an obstruction. Commonly, stents are inserted into the lumen in a non-expanded form and are then expanded autonomously (or with the aid of a second device) in situ. When used in coronary artery procedures for relieving stenosis, stents are placed percutaneously through the femoral artery. In this type of procedure, stents are delivered on a catheter and are either self-expanding or, in the majority of cases, expanded by a balloon. Self-explanding stents do not need a balloon to be deployed. Rather the stents are constructed using metals with spring-like or superelastic properties (i.e., Nitinol), which inherently exhibit constant radial support. Self-expanding stents are also often used in vessels close to the skin (i.e., carotid arteries) or vessels that can experience a lot of movement (i.e., popliteal artery). Due to a natural elastic recoil, self-expanding stents withstand pressure or shifting and maintain their shape.
As mentioned above, the typical method of expansion for balloon expanded stents occurs through the use of a catheter mounted angioplasty balloon, which is inflated within the stenosed vessel or body passageway, in order to shear and disrupt the obstructions associated with the wall components of the vessel and to obtain an enlarged lumen.
Balloon-expandable stents involve crimping the device onto an angioplasty balloon. The stent takes shape as the balloon is inflated and remains in place when the balloon and delivery system are deflated and removed.
In addition, balloon-expandable stents are available either pre-mounted or unmounted. A pre-mounted system has the stent already crimped on a balloon, while an unmounted system gives the physician the option as to what combination of devices (catheters and stents) to use. Accordingly, for these types of procedures, the stent is first introduced into the blood vessel on a balloon catheter. Then, the balloon is inflated causing the stent to expand and press against the vessel wall. After expanding the stent, the balloon is deflated and withdrawn from the vessel together with the catheter. Once the balloon is withdrawn, the stent stays in place permanently, holding the vessel open and improving the flow of blood.
In the absence of a stent, restenosis may occur as a result of elastic recoil of the stenotic lesion. Although a number of stent designs have been reported, these designs have suffered from a number of limitations. Some of these limitations include premature deployment of the stent due to circumstances such as over-manipulation when traversing tortuous vessels or the inability to maintain the stent secured to the balloon due to migration, slippage, etc.
Accordingly, to date, there have not been any stent designs, that specifically address these drawbacks in an efficient and cost effective manner.
BRIEF SUMMARY OF THE INVENTION
The present invention relates to an apparatus and method for stenting a vessel in conjunction with a particular new and useful stent having a lattice of interconnecting elements defining a substantially cylindrical configuration. The lattice has a first open end and a second open end wherein the lattice is movable between a locked configuration and an open configuration.
One embodiment of the stent includes a plurality of bridges connecting the interconnecting elements wherein each bridge interlocks with an adjacent bridge in the locked configuration and wherein each bridge separates from the adjacent bridge in the open configuration.
In another embodiment, the interlocking elements include a plurality of struts wherein each strut interlocks with an adjacent strut in the locked configuration and each strut separates from the adjacent strut in the open configuration.
For the interlocking bridge embodiment, each bridge has a projection and a base wherein the base has a projection holding section for receiving the projection from an adjacent bridge. Likewise, for the interlocking strut embodiment, each strut has a projection and a base wherein the base has a projection holding section for receiving the projection from an adjacent strut. Accordingly, for both of the stent embodiments identified above, several features are in common. For instance, the interlocking elements comprise a plurality of adjacent sections. Additionally, the adjacent sections comprise adjacent hoops wherein each hoop comprises a plurality of loops. Each loop comprises at least one strut.
For both the interlocking bridge embodiment and the interlocking strut embodiment, lateral arms extend from the base. Moreover, the projection holding section of the base has an opening therein for receiving the projection. An extension is connected between the base and the projection, and, for the interlocking bridge embodiment, the extension includes a neck wherein the projection is located at a superior position on the neck.
The projection also includes at least one lateral lip and the projection holding section includes at least one lateral ledge for releasably engaging the at least one lateral lip of the projection. The projection also includes at least one sidewall adjacent to the at least one lateral lip. Additionally, the projection holding section includes at least one lateral depression adjacent to the at least one lateral ledge for releasably engaging the at least one sidewall of the projection.
Although these features are intended to encompass any suitable configuration, in a preferred embodiment, the at least one sidewall is curved and the at least one depression is curved wherein these elements are aligned, snapped-fit or interlock in a puzzle-lock manner. Moreover, the lateral arms of the base connect directly to the interconnecting elements of the lattice.
The stent of the present invention is directed toward both a balloon actuated stent and a self-expanding stent. The stent is made of any suitable material. In one embodiment, the stent is made of an alloy such as stainless steel. In another preferred embodiment, the stent is made of a nickel titanium (Nitinol) alloy. Moreover, this material or any other super-elastic alloy is suitable for the stent according to the present invention. In these self-expanding stent embodiments, the stent is a crush recoverable stent.
The present invention is also directed toward an apparatus and method for stenting a vessel utilizing the stent embodiments described above, e.g., a stent having a lattice of interconnecting elements and including interlocking features such as a plurality of interlocking bridges in one embodiment or a plurality of interlocking struts in another embodiment.
The apparatus further includes a catheter having an inner sleeve and an expandable member on the inner sleeve wherein the expandable member is movable between a collapsed state and an expanded state. One of the stent embodiments described above is secured to the catheter over the expandable member when the expandable member is in the collapsed state and the stent is in the locked configuration. The stent is separated or deployed from the catheter when the expandable member is in the expanded state and the stent is in the open configuration. The apparatus further includes a cover movably disposed over the stent. The cover is an outer sheath made of a polymer material. Additionally, the expandable member is an inflatable balloon.
The method for stenting a vessel according to the present invention comprises the steps of providing the apparatus according to the present invention have one of the stent embodiments, e.g., the interlocking bridge embodiment or the interlocking strut embodiment, and inserting the apparatus within a vessel. The distal end of the apparatus is positioned at a desired location within the vessel and the stent is deployed to the open configuration with the expandable member.
Additionally, the method further includes providing the cover movably disposed over the stent for preventing the stent from moving to the open configuration until desired. The method further comprises deploying the stent to the open configuration by inflation of the expandable member.
Additionally, the method further comprises securing the stent to the catheter by interlocking the bridges (for the interlocking bridge embodiment) or by interlocking the struts (for the interlocking strut embodiment) prior to performing certain steps according to the present invention. Lastly, the method according to the present invention also comprises removing the catheter from the patient after the deployment of the stent.
BRIEF DESCRIPTION OF THE DRAWINGS
The novel features of the invention are set forth with particularity in the appended claims. The invention itself, however, both as to organization and methods of operation, together with further objects and advantages thereof, may be best understood by reference to the following description, taken in conjunction with the accompanying drawings in which:
FIG. 1A is a perspective view of a first embodiment of a stent in a closed configuration in accordance with the present invention;
FIG. 1B is a perspective view of a second embodiment of a stent in a closed configuration in accordance with the present invention;
FIG. 2A is a partial side plan view of an interlocking bridge for the stent of FIG. 1A;
FIG. 2B is a partial side plan view of an interlocking strut for the stent of FIG. 1B;
FIG. 3A is a partial side view of the lattice of the stent of FIG. 1A;
FIG. 3B is a partial side view of the lattice of the stent of FIG. 1B;
FIG. 4A is a partial perspective view of the stent of FIG. 1A in an open configuration;
FIG. 4B is a partial perspective view of the stent of FIG. 1B in an open configuration;
FIG. 5A is a partial perspective view of a distal end of an apparatus according to the present invention utilizing the stent of FIG. 1A; and
FIG. 5B is a partial perspective view of a distal end of an apparatus according to the present invention utilizing the stent of FIG. 1B.
DETAILED DESCRIPTION OF THE INVENTION
In FIGS. 1A, 1B, 4A and 4B, a stent 100 that is an expandable prosthesis for a body passageway is illustrated. It should be understood that the terms “stent” and “prosthesis” are interchangeably used to some extent in describing the present invention, insofar as the method, apparatus, and structures of the present invention may be utilized not only in connection with an expandable intraluminal vascular graft for expanding partially occluded segments of a blood vessel, duct or body passageways, such as within an organ, but may so be utilized for many other purposes as an expandable prosthesis for many other types of body passageways. For example, expandable prostheses may also be used for such purposes as: (1) supportive graft placement within blocked arteries opened by transluminal recanalization, but which are likely to collapse in the absence of internal support; (2) similar use following catheter passage through mediastinal and other veins occluded by inoperable cancers; (3) reinforcement of catheter created intrahepatic communications between portal and hepatic veins in patients suffering from portal hypertension; (4) supportive graft placement of narrowing of the esophagus, the intestine, the ureters, the uretha, etc.; (5) intraluminally bypassing a defect such as an aneurysm or blockage within a vessel or organ; and (6) supportive graft reinforcement of reopened and previously obstructed bile ducts. Accordingly, use of the term “prothesis” encompasses the foregoing usages within various types of body passageways, and the use of the term “intraluminal graft” encompasses use for expanding the lumen of a body passageway. Further in this regard, the term “body passageway” encompasses any lumen or duct within the human body, such as those previously described, as well as any vein, artery, or blood vessel within the human vascular system.
The stent 100 is an expandable lattice structure made of any suitable material which is compatible with the human body and the bodily fluids (not shown) with which the stent 100 may come into contact. The lattice structure is an arrangement of interconnecting elements made of a material which has the requisite strength and elasticity characteristics to permit the tubular shaped stent 100 to be expanded from the closed configuration shown in FIGS. 1A and 1B to the expanded configuration shown in FIGS. 4A and 4B and further to permit the stent 100 to retain its expanded configuration at the enlarged diameter d1. Suitable materials for the fabrication of the stent 100 include silver, tantalum, stainless steel, gold, titanium or any suitable plastic material having the requisite characteristics previously described. In one embodiment, the stent is fabricated from 316L stainless steel alloy
In a preferred embodiment, the stent 100 comprises a superelastic alloy such as nickel titanium (NiTi, e.g., Nitinol). More preferably, the stent 100 is formed from an alloy comprising from about 50.5 to 60.0% Ni by atomic weight and the remainder Ti. Even more preferably, the stent 100 is formed from an alloy comprising about 55% Ni and about 45% Ti. The stent 100 is preferably designed such that it is superelastic at body temperature, and preferably has an Af temperature in the range from about 24° C. to about 37° C. The superelastic design of the stent 100 makes it crush recoverable and thus suitable as a stent or frame for any number of vascular devices for different applications.
The stent 100 comprises a tubular configuration formed by a lattice of interconnecting elements defining a substantially cylindrical configuration and having front and back open ends 102, 104 and defining a longitudinal axis 103 extending therebetween. In its closed configuration, the stent 100 has a first diameter (d1) for insertion into a patient and navigation through the vessels and, in its open configuration, a second diameter (d2), as shown in FIGS. 4A and 4B, for deployment into the target area of a vessel with the second diameter being greater than the first diameter. The stent 100 comprises a plurality of adjacent hoops 106(a)-(d) extending between the front and back ends 102, 104. The hoops 106(a)-(d) include a plurality of longitudinally arranged struts 108 and a plurality of loops 110 connecting adjacent struts 108. Adjacent struts 108 are connected at opposite ends so as to form a substantially S or Z shape pattern. The plurality of loops 110 have a substantially semi-circular configuration and are substantially symmetric about their centers.
The stent 100 further comprises a plurality of bridges 114, which connect adjacent hoops 106(a)-(d). The details of the bridges 114 are more fully illustrated in FIGS. 2A, and 3A and described below. Each bridge comprises two ends wherein one end of each bridge 114 is attached to one loop 110 on one hoop 106(a) and the other end of each bridge 114 is attached to one loop 110 on an adjacent hoop 106(b). The bridges 114 connect adjacent hoops 106(a)-(d) together at bridge to loop connection regions 120,122 as shown in FIG. 2A.
The above-described geometry better distributes strain throughout the stent 100, prevents metal to metal contact where the stent 100 is bent, and minimizes the opening between the features of the stent 100; namely, struts 108, loops 110 and bridges 114. The number of and nature of the design of the struts, loops and bridges are important design factors when determining the working properties and fatigue life properties of the stent 100. It was previously thought that in order to improve the rigidity of the stent, struts should be large, and thus there should be fewer struts 108 per hoop 106(a)-(d). However, it is now known that stents 100 having smaller struts 108 and more struts 108 per hoop 106(a)-(d) improve the construction of the stent 100 and provide greater rigidity. Preferably, each hoop 106(a)-(d) has between twenty-four (24) to thirty-six (36) or more struts 108. It has been determined that a stent having a ratio of number of struts per hoop to strut length which is greater than four hundred has increased rigidity over prior art stents which typically have a ratio of under two hundred. The length of a strut is measured in its compressed state parallel to the longitudinal axis 103 of the stent 100 as illustrated in FIG. 1A.
FIG. 4A illustrates the stent 100 in its open or expanded state. As may be seen from a comparison between the stent 100 configuration illustrated in FIG. 1A and the stent 100 configuration illustrated in FIG. 4A, the geometry of the stent 100 changes quite significantly as it is deployed from its unexpanded state (closed or locked configuration) to its expanded state (open or unlocked configuration). As the stent 100 undergoes diametric change, the strut angle and strain levels in the loops 110 and bridges 114 are affected. Preferably, all of the stent features will strain in a predictable manner so that the stent 100 is reliable and uniform in strength. In addition, it is preferable to minimize the maximum strain experienced by the struts 108, loops 110 and bridges 114 since Nitinol properties are more generally limited by strain rather than by stress. The embodiments illustrated in FIGS. 1A-5B has a design to help minimize forces such as strain.
FIG. 1A illustrates the first embodiment of the stent 100 according to the present invention including a plurality of interlocking bridges 114 connecting adjacent hoops 106(a)-(d). In this embodiment, as best illustrated in FIG. 2A, stent 100 has bridges 114 wherein each bridge 114 includes a base 126. The base 126 has a pair of laterally extending arms 128 wherein each end of the lateral arms 128 are connected directly to a loop 110 at loop connection regions 120 and 122. Accordingly, one laterally extending arm connects to one of the adjacent hoops 106(a)-(d) at the loop connection region 120 of one loop 110 and the other lateral extending arm 128 of the bridge 114 is connected to an adjacent loop 110 at the loop connection region 122. Thus, the bridge 114 alternatively connects adjacent hoops 106(a)-(d).
The bridge 114 further includes an extension 130 extending in a superior direction from the base 126. The extension 130 includes a neck 131 at the superior end of the extension 130. A projection 132 is fixed to the superior end of the neck 131 of the extension 130. Although the projection 132 can comprise any desired configuration, one preferred configuration for the projection 132 includes a pair of lateral lips 134 laterally extending from the neck 131 and a pair of lateral sidewalls 136 extending from the lateral lips 134 respectively. In this embodiment, the lateral sidewalls 136 have a curved-shape. Additionally, the projection 132 further includes an upper edge 137 extending between the lateral sidewalls 136.
The bridge 114 further includes a projection holding section 140 inferior to the extension 130 at the base 126. The projection holding section 140 is defined by an opening 142 in the base 126. The projection holding section 140 further includes a pair of lateral ledges 144 extending from each side of the opening 142. The projection holding section 140 further includes a lateral depression 146 extending from each lateral ledge 144. Each lateral depression 146 also has a curved-shape for this embodiment. Additionally, the projection holding section 140 includes an upper edge 147 extending between each lateral depression 146.
The projection holding section 140 is shaped to fit and receive in a snap-fit or puzzle-lock manner the projection 132 of an adjacent bridge 114. Due to the unique configuration of the bridge 114, the projection 132 of a first bridge 114 is interlocked with the projection holding section 140 of a second bridge 114. The interlocking of bridges 114, which can be adjacent bridges, is accomplished by insertion of the projection 132 of the first bridge 114 into the central opening 142 of the projection holding section 140 of the second bridge 114 such that the lateral lips 134 releasably engage the lateral ledges 144 of the projection holding section 140. Moreover, the lateral sidewalls 136 of the projection 132 mates, in a releasable fashion, with the lateral depressions 146 of the projection holding section 140 of the second bridge 114. Furthermore, the upper edge 137 of the projection 132 of the first bridge 114 releasably mates with the upper edge 147 of the projection holding section 140 of the second bridge 114. Accordingly, this arrangement insures for an interlocking of the first and second bridges 114, e.g., adjacent bridges 114, in a puzzle-like manner. This arrangement of interlocking bridges 114 is clearly illustrated in FIG. 3A. When deployed to an open configuration, the stent 100 for the interlocking bridge embodiment described above expands to a width D2 as shown in FIG. 4A.
A second embodiment for the stent 100 is shown in FIG. 1B and includes a plurality of interlocking struts 108 a. In this embodiment, adjacent hoops 106(a)-(d) are connected to each other by nonlocking bridges 114 a.
For the embodiment of FIG. 1B (the interlocking strut embodiment), a plurality of interlocking struts 108 a are utilized in order to interlock by releasable engagement a first strut 108 a with a second strut 108 a as best shown in FIG. 3B.
For purposes of this disclosure, the same reference numerals are used to designate like or similar features for both the interlocking bridge 114 embodiment (FIG. 1A) and the interlocking strut 108 a embodiment (FIG. 1B). Accordingly, each interlocking strut 108 a includes base 126 and laterally extending sidearms 128 as shown in FIG. 2B.
As illustrated in FIG. 2B, the strut 108 a further includes extension 130 extending in a superior direction from the base 126. Projection 132 is fixed to the superior end of the extension 130. Although the projection 132 can comprise any desired configuration, one preferred configuration for the projection 132 includes a pair of lateral lips 134 laterally extending from the extension 130 and a pair of lateral sidewalls 136 extending from the lateral lips 134 respectively. In this embodiment, the lateral sidewalls 136 have a curved-shape. Additionally, the projection 132 further includes upper edge 137 extending between the sidewalls 136.
The strut 108 a (of the interlocking strut embodiment) further includes projection holding section 140 inferior to the extension 130 at the base 126. The projection holding section 140 is defined by opening 142 in the base 126. The projection holding section 140 further includes a pair of lateral ledges 144 extending from each side of the opening 142. The projection holding section 140 further includes lateral depression 146 extending from each lateral ledge 144. Each lateral depression 146 also has a curved-shape for this embodiment. Additionally, the projection holding section 140 includes upper edge 147 extending between each lateral depression 146.
As best illustrated in FIG. 3B, the projection holding section 140 is shaped to fit and receive in a snap-fit or puzzle-lock manner the projection 132 of an adjacent strut 108 a. Due to the unique configuration of the strut 108 a, the projection 132 of a first strut 108 a is interlocked with the projection holding section 140 of a second strut 108 a. The interlocking of struts 108 a, which can be adjacent struts, is accomplished by insertion of the projection 132 of the first strut 108 a into the central opening 142 of the projection holding section 140 of the second strut 108 a such that the lateral lips 134 releasably engage the lateral ledges 144 of the projection holding section 140. Moreover, the lateral sidewalls 136 of the projection 132 mates, in a releasable fashion, with the lateral depressions 146 of the projection holding section 140 of the second strut 108 a. Furthermore, the upper edge 137 of the projection 132 of the first strut 108 a releasably mates with the upper edge 147 of the projection holding section 140 of the second strut 108 a. Accordingly, this arrangement insures for an interlocking of the first and second struts 108 a, e.g., adjacent struts 108 a, in a puzzle-like manner. This arrangement of interlocking struts 108 a is clearly illustrated in FIG. 3B. Thus, the first strut 108 a releasably engages with or interlocks with the second strut 108 a in a puzzle-lock manner.
As mentioned above with the interlocking bridge embodiment of FIG. 4A, as shown in FIG. 4B, the stent 100 having the interlocking struts 108 a (the inerlocking strut embodiment) is deployed or expanded to an open configuration having a width D2.
The stent 100 according to the present invention for both the interlocking bridge 114 embodiment and the interlocking strut 108 a embodiment is directed toward both deployment or expansion through an expandable member such as a balloon (to be described in greater detail below) and a self-expanding stent, i.e., a stent that is crush recoverable.
The present invention also includes an apparatus and method for stenting a vessel utilizing the stent 100 (both the interlocking bridge 114 embodiment and the interlocking strut 108 a embodiment). The stenting apparatus according to the present invention is generally designated 200 as best shown in FIGS. 5A and 5B. FIG. 5A illustrates the apparatus 200 (as a catheter) which includes the stent 100 (the interlock bridge 114 embodiment) and FIG. 5B illustrates the apparatus 200 including the second embodiment for the stent 100 (the interlocking strut 108 a embodiment). As illustrated in FIGS. 5A and 5B, the catheter 200 has a distal end 210 culminating in a distal tip 215. The catheter 200 includes an inner sleeve 220 extending to the distal tip 215. An expandable member 230, such as an inflatable balloon, is fixed to the inner sleeve 220 at the distal end 210 of the catheter 200. As is well understood in the field, the expandable member 230 is expanded, such as through inflation with a hydraulic or pneumatic fluid, and is expandable from a collapsed or closed configuration to an open or expanded configuration. The stent 100 (both embodiments of FIGS. 1A and 1B) according to the present invention are secured to the distal end of the catheter 200 by closing the stent 100 over the expandable member 230 and the inner sleeve 220 as best illustrated in FIGS. 5A and 5B. The stent 100 is secured to the catheter 200 by closing the stent 100 respectively by moving the stent 100 and to its locked configuration. As described above, the locked configuration for the stent 100 includes interlocking the bridges 114 (for the interlocking bridge embodiment FIG. 5A) and for interlocking the struts 108 a (for the intrelocking strut embodiment FIG. 5B) in the respective manner described above.
In securing the stent 100 to the catheter distal end 210 for the interlocking bridge embodiment of FIG. 5A, the bridges 114 are moved and interlocked (as shown in FIG. 3A) such that the stent 100 is locked and in its closed configuration over the expandable member 230.
In securing the stent 100 to the catheter distal end 210 for the interlocking strut embodiment of FIG. 5B, the struts 108 a are moved and interlocked (as shown in FIG. 3B) such that the stent 100 is locked and in its closed configuration over the expandable member 230.
For both embodiments mentioned above, the stent 100 is thereby secured to the catheter 200 until deployment is desired. An outer sheath 240, which is made of a polymer material such as polyethylene, is used as a cover for the catheter distal end 210 and serves as an additional form of protection for securing of the stent 100 (both embodiments) to the catheter distal end 210. The cover 240 is movably positioned or movably disposed from the catheter distal end 210 in order to provide both the protection as described above as well as the unimpeded deployment of the stent 100 upon positioning of the stent 100 at its desired location.
The method of utilizing the catheter 200 according to the present invention includes first identifying a location in a patient's body for deployment of the stent 100. Upon identifying the desired deployment location, the catheter 200 is inserted within a vessel in the patient's body. The catheter 200 is used to traverse the vessel until reaching the desired location wherein the distal end 210 of the catheter 200 is positioned at the desired location within the vessel. At this point, the stent 100 is deployed to its open configuration by expanding the expandable member 230 such as by inflation. If the cover 240 is utilized to further protect and secure the stent 100 to the catheter distal end 210, the cover 240 is removed from the distal end 210 prior to expansion of the expandable member 230.
Upon expanding the stent 100 to its open configuration, the expandable member 230 is then collapsed, for instance through deflation of the expandable member, whereby the catheter 200 is removed from the deployment site of the vessel and patient's body altogether.
While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. Accordingly, it is intended that the invention be limited only by the spirit and scope of the appended claims.

Claims (36)

What is claimed is:
1. A stent comprising:
a lattice of interconnecting elements defining a substantially cylindrical configuration having a first open end and a second open end, the lattice having a locked configuration and an open configuration; and
a plurality of bridges connecting the interconnecting elements, each bridge interlocking with an adjacent bridge in the locked configuration and each bridge separating from the adjacent bridge in the open configuration, each bridge having a projection and a base, the base having a projection holding section for receiving the projection from the adjacent bridge, the interconnecting elements comprising a plurality of adjacent sections, wherein the adjacent sections comprise adjacent hoops, and each hoop comprises a plurality of loops.
2. The stent according to claim 1, wherein each hoop comprises at least one strut.
3. The stent according to claim 1, wherein each bridge has lateral arms extending from the base.
4. The stent according to claim 3, wherein the projection holding section has an opening therein.
5. The stent according to claim 4, wherein an extension is connected between the base and the projection.
6. The stent according to claim 5, wherein the extension includes a neck and the projection is located at a superior position on the neck.
7. The stent according to claim 6, wherein the projection includes at least one lateral lip.
8. The stent according to claim 7, wherein the projection holding section includes at least one lateral ledge for releasable engaging the at least one lateral lip of the projection.
9. The stent according to claim 8, wherein the projection includes at least one sidewall adjacent the at least one lateral lip.
10. The stent according to claim 9, wherein the projection holding section includes at least one lateral depression adjacent the at least one lateral ledge for releasably engaging the at least one sidewall of the projection.
11. The stent according to claim 10, wherein the at least one sidewall is curved.
12. The stent according to claim 11, wherein the at least one lateral depression is curved.
13. The stent according to claim 12, wherein the lateral arms connect the interconnecting elements.
14. The stent according to claim 1, wherein the stent is made of an alloy.
15. The stent according to claim 14, wherein the stent is made of stainless steel.
16. The stent according to claim 1, wherein the stent is crush recoverable.
17. The stent according to claim 16 wherein the stent is made of nickel titanium (NiTi).
18. The stent according to claim 14, wherein the stent is made of a superelastic alloy.
19. The stent according to claim 18, wherein the stent is made of nickel titanium (NiTi).
20. A stent comprising:
a lattice of interconnecting elements defining a substantially cylindrical configuration having a first open end and a second open end, the lattice having a locked configuration and an open configuration, the interconnecting elements including a plurality of struts, each strut interlocking with an adjacent strut in the locked configuration and each strut separating from the adjacent strut in the open configuration, and at least one bridge connected between a pair of struts, wherein each strut has a projection and a base, the base having a projection holding section for receiving the projection from the adjacent strut, and the interconnecting elements comprising a plurality of adjacent sections, the adjacent sections comprising adjacent hoops, each hoop comprising a plurality of loops.
21. The stent according to claim 20, wherein each hoop comprises at least one strut.
22. The stent according to claim 20, wherein each strut has lateral arms extending from the base.
23. The stent according to claim 22, wherein the projection holding section has an opening therein.
24. The stent according to claim 23, wherein an extension is connected between the base and the projection.
25. The stent according to claim 24, wherein the projection includes at least one lateral lip.
26. The stent according to claim 25, wherein the projection holding section includes at least one lateral ledge for releasable engaging the at least one lateral lip of the projection.
27. The stent according to claim 26, wherein the projection includes at least one sidewall adjacent the at least one lateral lip.
28. The stent according to claim 27, wherein the projection holding section includes at least one lateral depression adjacent the at least one lateral ledge for releasable engaging the at least one sidewall of the projection.
29. The stent according to claim 28, wherein the at least one sidewall is curved.
30. The stent according to claim 29, wherein the at least one depression is curved.
31. The stent according to claim 20, wherein the stent is made of an alloy.
32. The stent according to claim 31, wherein the stent is made of stainless steel.
33. The stent according to claim 20, wherein the stent is crush recoverable.
34. The stent according to claim 33 wherein the stent is made of nickel titanium (NiTi).
35. The stent according to claim 31, wherein the stent is made of a superelastic alloy.
36. The stent according to claim 35, wherein the stent is made of nickel titanium (NiTi).
US09/877,506 2001-06-08 2001-06-08 Stent with interlocking elements Expired - Lifetime US6562067B2 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
US09/877,672 US6599314B2 (en) 2001-06-08 2001-06-08 Apparatus and method for stenting a vessel using balloon-actuated stent with interlocking elements
US09/877,506 US6562067B2 (en) 2001-06-08 2001-06-08 Stent with interlocking elements
IL14964602A IL149646A0 (en) 2001-06-08 2002-05-14 Apparatus and method for stenting a vessel using balloon-actuated stent with interlocking elements
AU40658/02A AU782122C (en) 2001-06-08 2002-05-15 Apparatus and method for stenting a vessel using balloon- actuated stent with interlocking elements
EP02253789A EP1266638B1 (en) 2001-06-08 2002-05-30 Balloon-actuated stent with interlocking elements
ES02253789T ES2250587T3 (en) 2001-06-08 2002-05-30 STENT WITH INTERLOCK ELEMENTS OPERATED BY BALL.
DE60206694T DE60206694T2 (en) 2001-06-08 2002-05-30 Balloon-actuated stent with lockable elements
DK02253789T DK1266638T3 (en) 2001-06-08 2002-05-30 Balloon-driven stent with interlocking elements
AT02253789T ATE306874T1 (en) 2001-06-08 2002-05-30 BALLOON ACTUATED STENT WITH LOCKING ELEMENTS
CA002389401A CA2389401C (en) 2001-06-08 2002-06-05 Apparatus and method for stenting a vessel using balloon-actuated stent with interlocking elements
JP2002167691A JP4233810B2 (en) 2001-06-08 2002-06-07 Vasodilator
KR1020020031823A KR100855889B1 (en) 2001-06-08 2002-06-07 Apparatus and method for stenting a vessel using balloon-actuated stent with interlocking elements

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/877,672 US6599314B2 (en) 2001-06-08 2001-06-08 Apparatus and method for stenting a vessel using balloon-actuated stent with interlocking elements
US09/877,506 US6562067B2 (en) 2001-06-08 2001-06-08 Stent with interlocking elements

Publications (2)

Publication Number Publication Date
US20020188347A1 US20020188347A1 (en) 2002-12-12
US6562067B2 true US6562067B2 (en) 2003-05-13

Family

ID=39267971

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/877,672 Expired - Lifetime US6599314B2 (en) 2001-06-08 2001-06-08 Apparatus and method for stenting a vessel using balloon-actuated stent with interlocking elements
US09/877,506 Expired - Lifetime US6562067B2 (en) 2001-06-08 2001-06-08 Stent with interlocking elements

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/877,672 Expired - Lifetime US6599314B2 (en) 2001-06-08 2001-06-08 Apparatus and method for stenting a vessel using balloon-actuated stent with interlocking elements

Country Status (11)

Country Link
US (2) US6599314B2 (en)
EP (1) EP1266638B1 (en)
JP (1) JP4233810B2 (en)
KR (1) KR100855889B1 (en)
AT (1) ATE306874T1 (en)
AU (1) AU782122C (en)
CA (1) CA2389401C (en)
DE (1) DE60206694T2 (en)
DK (1) DK1266638T3 (en)
ES (1) ES2250587T3 (en)
IL (1) IL149646A0 (en)

Cited By (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030208263A1 (en) * 1994-05-19 2003-11-06 Burmeister Paul H. Tissue supporting devices
US6669723B2 (en) * 1998-03-04 2003-12-30 Scimed Life Systems, Inc. Stent having variable properties and method of its use
US20040158321A1 (en) * 2003-02-12 2004-08-12 Cardiac Dimensions, Inc. Method of implanting a mitral valve therapy device
US20040193260A1 (en) * 2001-12-05 2004-09-30 Alferness Clifton A. Anchor and pull mitral valve device and method
US20040220657A1 (en) * 2003-05-02 2004-11-04 Cardiac Dimensions, Inc., A Washington Corporation Tissue shaping device with conformable anchors
US20040249452A1 (en) * 2001-11-01 2004-12-09 Adams John M. Focused compression mitral valve device and method
US20050010240A1 (en) * 2003-06-05 2005-01-13 Cardiac Dimensions Inc., A Washington Corporation Device and method for modifying the shape of a body organ
US20050021121A1 (en) * 2001-11-01 2005-01-27 Cardiac Dimensions, Inc., A Delaware Corporation Adjustable height focal tissue deflector
US20050027351A1 (en) * 2001-05-14 2005-02-03 Cardiac Dimensions, Inc. A Washington Corporation Mitral valve regurgitation treatment device and method
US20050096666A1 (en) * 2002-12-05 2005-05-05 Gordon Lucas S. Percutaneous mitral valve annuloplasty delivery system
US20050119673A1 (en) * 2002-12-05 2005-06-02 Gordon Lucas S. Percutaneous mitral valve annuloplasty device delivery method
US20050125051A1 (en) * 2003-12-05 2005-06-09 Scimed Life Systems, Inc. Detachable segment stent
US20050137685A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc., A Washington Corporation Reduced length tissue shaping device
US20050137450A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc., A Washington Corporation Tapered connector for tissue shaping device
US20050137451A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc. A Washington Corporation Tissue shaping device with integral connector and crimp
US20050149179A1 (en) * 2002-05-08 2005-07-07 Mathis Mark L. Body lumen device anchor, device and assembly
US20050187606A1 (en) * 2004-02-20 2005-08-25 Scimed Life Systems, Inc. Stent with nested flexible connectors for flexibility and crimpability
US20050209690A1 (en) * 2002-01-30 2005-09-22 Mathis Mark L Body lumen shaping device with cardiac leads
US20050216077A1 (en) * 2002-01-30 2005-09-29 Mathis Mark L Fixed length anchor and pull mitral valve device and method
US20050272969A1 (en) * 2001-12-05 2005-12-08 Alferness Clifton A Device and method for modifying the shape of a body organ
US20060020335A1 (en) * 2002-12-26 2006-01-26 Leonard Kowalsky System and method to effect the mitral valve annulus of a heart
US20060195175A1 (en) * 2005-02-25 2006-08-31 Abbott Laboratories Vascular Enterprises Limited Modular vascular prosthesis having axially variable properties and improved flexibility and methods of use
US20060271158A1 (en) * 2005-05-26 2006-11-30 Boston Scientific Scimed, Inc. Positional locking endoluminal device system
US20060271174A1 (en) * 2003-12-19 2006-11-30 Gregory Nieminen Mitral Valve Annuloplasty Device with Wide Anchor
US20060276891A1 (en) * 2003-12-19 2006-12-07 Gregory Nieminen Mitral Valve Annuloplasty Device with Twisted Anchor
US20070026132A1 (en) * 2002-11-15 2007-02-01 Williams Michael S Endoprostheses and methods of manufacture
US20070055293A1 (en) * 2001-12-05 2007-03-08 Alferness Clifton A Device and method for modifying the shape of a body organ
US20070135912A1 (en) * 2003-02-03 2007-06-14 Mathis Mark L Mitral valve device using conditioned shape memory alloy
US20070213810A1 (en) * 2005-03-14 2007-09-13 Richard Newhauser Segmented endoprosthesis
US20070239270A1 (en) * 2006-04-11 2007-10-11 Mathis Mark L Mitral Valve Annuloplasty Device with Vena Cava Anchor
US20080009663A1 (en) * 2006-07-10 2008-01-10 Michelle Bartning Method of treating urinary incontinence
US20080015679A1 (en) * 2003-05-02 2008-01-17 Mathis Mark L Device and Method for Modifying the Shape of a Body Organ
US20080033230A1 (en) * 2006-07-10 2008-02-07 Michelle Bartning Resilient device
US20080215135A1 (en) * 2005-02-17 2008-09-04 Jacques Seguin Device Allowing the Treatment of Bodily Conduits at an Area of a Bifurcation
US20090005848A1 (en) * 2005-02-25 2009-01-01 Abbott Laboratories Vascular Enterprises Limited Modular vascular prosthesis and methods of use
US20090234428A1 (en) * 2004-06-28 2009-09-17 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US20090248137A1 (en) * 2001-09-11 2009-10-01 Xtent, Inc. Expandable stent
US20100030324A1 (en) * 2008-08-04 2010-02-04 Jacques Seguin Method for treating a body lumen
US20100152836A1 (en) * 2000-03-06 2010-06-17 Boston Scientific Scimed, Inc. Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof
US20100218359A1 (en) * 2006-07-10 2010-09-02 Michelle Bartning Resilient device
US7803180B2 (en) 2005-04-04 2010-09-28 Flexible Stenting Solutions, Inc. Flexible stent
US20100256740A1 (en) * 2005-08-29 2010-10-07 Limon Timothy A Locking Polymer Stents
US20110093059A1 (en) * 2009-10-20 2011-04-21 Svelte Medical Systems, Inc. Hybrid stent with helical connectors
US20110130822A1 (en) * 2007-07-20 2011-06-02 Orbusneich Medical, Inc. Bioabsorbable Polymeric Compositions and Medical Devices
US20110152604A1 (en) * 2009-12-23 2011-06-23 Hull Jr Raymond J Intravaginal incontinence device
US8006594B2 (en) 2008-08-11 2011-08-30 Cardiac Dimensions, Inc. Catheter cutting tool
US8043366B2 (en) 2005-09-08 2011-10-25 Boston Scientific Scimed, Inc. Overlapping stent
US20110288622A1 (en) * 2010-05-18 2011-11-24 Abbott Cardiovascular Systems, Inc. Expandable endoprostheses, systems, and methods for treating a bifurcated lumen
US8070794B2 (en) 2007-01-09 2011-12-06 Stentys S.A.S. Frangible bridge structure for a stent, and stent including such bridge structures
US8083788B2 (en) 2001-12-03 2011-12-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US8177831B2 (en) 2001-12-03 2012-05-15 Xtent, Inc. Stent delivery apparatus and method
US20120165930A1 (en) * 2010-12-23 2012-06-28 The Foundy, Llc System for mitral valve repair and replacement
US8282680B2 (en) 2003-01-17 2012-10-09 J. W. Medical Systems Ltd. Multiple independent nested stent structures and methods for their preparation and deployment
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8460358B2 (en) 2004-03-30 2013-06-11 J.W. Medical Systems, Ltd. Rapid exchange interventional devices and methods
US8470014B2 (en) 2004-08-25 2013-06-25 Advanced Cardiovascular Systems, Inc. Stent-catheter assembly with a releasable connection for stent retention
US8486132B2 (en) 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8500794B2 (en) 2007-08-02 2013-08-06 Flexible Stenting Solutions, Inc. Flexible stent
US8568469B1 (en) * 2004-06-28 2013-10-29 Advanced Cardiovascular Systems, Inc. Stent locking element and a method of securing a stent on a delivery system
US8574282B2 (en) 2001-12-03 2013-11-05 J.W. Medical Systems Ltd. Apparatus and methods for delivery of braided prostheses
US8585747B2 (en) 2003-12-23 2013-11-19 J.W. Medical Systems Ltd. Devices and methods for controlling and indicating the length of an interventional element
US8652198B2 (en) 2006-03-20 2014-02-18 J.W. Medical Systems Ltd. Apparatus and methods for deployment of linked prosthetic segments
US8702781B2 (en) 2001-12-03 2014-04-22 J.W. Medical Systems Ltd. Apparatus and methods for delivery of multiple distributed stents
US8956398B2 (en) 2001-12-03 2015-02-17 J.W. Medical Systems Ltd. Custom length stent apparatus
US8980297B2 (en) 2007-02-20 2015-03-17 J.W. Medical Systems Ltd. Thermo-mechanically controlled implants and methods of use
US9034033B2 (en) 2011-10-19 2015-05-19 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9101503B2 (en) 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
US9125740B2 (en) 2011-06-21 2015-09-08 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9149376B2 (en) 2008-10-06 2015-10-06 Cordis Corporation Reconstrainable stent delivery system
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US9901443B2 (en) 2011-10-19 2018-02-27 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
US10111747B2 (en) 2013-05-20 2018-10-30 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
US10238490B2 (en) 2015-08-21 2019-03-26 Twelve, Inc. Implant heart valve devices, mitral valve repair devices and associated systems and methods
US10265172B2 (en) 2016-04-29 2019-04-23 Medtronic Vascular, Inc. Prosthetic heart valve devices with tethered anchors and associated systems and methods
US10390953B2 (en) 2017-03-08 2019-08-27 Cardiac Dimensions Pty. Ltd. Methods and devices for reducing paravalvular leakage
US10433961B2 (en) 2017-04-18 2019-10-08 Twelve, Inc. Delivery systems with tethers for prosthetic heart valve devices and associated methods
US10575950B2 (en) 2017-04-18 2020-03-03 Twelve, Inc. Hydraulic systems for delivering prosthetic heart valve devices and associated methods
US10603152B2 (en) 2017-08-31 2020-03-31 Kimberly-Clark Worldwide, Inc. Multi-component vaginal insert
US10603151B2 (en) 2018-08-27 2020-03-31 Kimberly-Clark Worldwide, Inc. Multi-component vaginal insert
US10646338B2 (en) 2017-06-02 2020-05-12 Twelve, Inc. Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods
US10702378B2 (en) 2017-04-18 2020-07-07 Twelve, Inc. Prosthetic heart valve device and associated systems and methods
US10702380B2 (en) 2011-10-19 2020-07-07 Twelve, Inc. Devices, systems and methods for heart valve replacement
US10709591B2 (en) 2017-06-06 2020-07-14 Twelve, Inc. Crimping device and method for loading stents and prosthetic heart valves
US10729541B2 (en) 2017-07-06 2020-08-04 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10786352B2 (en) 2017-07-06 2020-09-29 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10792151B2 (en) 2017-05-11 2020-10-06 Twelve, Inc. Delivery systems for delivering prosthetic heart valve devices and associated methods
US11033257B2 (en) 2005-01-20 2021-06-15 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US11202704B2 (en) 2011-10-19 2021-12-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11285005B2 (en) 2006-07-17 2022-03-29 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US11596771B2 (en) 2020-12-14 2023-03-07 Cardiac Dimensions Pty. Ltd. Modular pre-loaded medical implants and delivery systems

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
DE20122506U1 (en) 2000-10-16 2005-12-08 Conor Medsystems, Inc., Menlo Park Expandable medical device for delivering a beneficial agent
US6764507B2 (en) * 2000-10-16 2004-07-20 Conor Medsystems, Inc. Expandable medical device with improved spatial distribution
EP1258230A3 (en) 2001-03-29 2003-12-10 CardioSafe Ltd Balloon catheter device
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
US7309350B2 (en) 2001-12-03 2007-12-18 Xtent, Inc. Apparatus and methods for deployment of vascular prostheses
US7294146B2 (en) 2001-12-03 2007-11-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
US20030135266A1 (en) 2001-12-03 2003-07-17 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US8080048B2 (en) 2001-12-03 2011-12-20 Xtent, Inc. Stent delivery for bifurcated vessels
US20030163190A1 (en) * 2002-02-25 2003-08-28 Scimed Life Systems, Inc. High temperature stent delivery system
US7918884B2 (en) * 2003-02-25 2011-04-05 Cordis Corporation Stent for treatment of bifurcated lesions
US7942920B2 (en) * 2003-02-25 2011-05-17 Cordis Corporation Stent with nested fingers for enhanced vessel coverage
US20040249442A1 (en) * 2003-02-26 2004-12-09 Fleming James A. Locking stent having multiple locking points
US20040167610A1 (en) 2003-02-26 2004-08-26 Fleming James A. Locking stent
US7214240B2 (en) * 2003-03-20 2007-05-08 Cordis Corporation Split-bridge stent design
US7241308B2 (en) 2003-06-09 2007-07-10 Xtent, Inc. Stent deployment systems and methods
US7757691B2 (en) * 2003-08-07 2010-07-20 Merit Medical Systems, Inc. Therapeutic medical appliance delivery and method of use
US7175654B2 (en) * 2003-10-16 2007-02-13 Cordis Corporation Stent design having stent segments which uncouple upon deployment
US20050085897A1 (en) * 2003-10-17 2005-04-21 Craig Bonsignore Stent design having independent stent segments which uncouple upon deployment
US7403966B2 (en) * 2003-12-08 2008-07-22 Freescale Semiconductor, Inc. Hardware for performing an arithmetic function
DE102004003093B4 (en) * 2004-01-21 2009-01-29 Admedes Schuessler Gmbh Stent for insertion and expansion in a lumen
EP1789107B1 (en) 2004-08-30 2009-05-27 Interstitial Therapeutics Medical stent provided with inhibitors of atp synthesis
US20060069424A1 (en) * 2004-09-27 2006-03-30 Xtent, Inc. Self-constrained segmented stents and methods for their deployment
US7320702B2 (en) 2005-06-08 2008-01-22 Xtent, Inc. Apparatus and methods for deployment of multiple custom-length prostheses (III)
US7938851B2 (en) 2005-06-08 2011-05-10 Xtent, Inc. Devices and methods for operating and controlling interventional apparatus
US8956400B2 (en) * 2005-10-14 2015-02-17 Flexible Stenting Solutions, Inc. Helical stent
US8652192B2 (en) * 2006-03-31 2014-02-18 St. Jude Medical, Cardiology Division, Inc. Stent and system and method for deploying a stent
AU2007258592B2 (en) 2006-06-06 2012-10-25 Cook Incorporated Stent with a crush-resistant zone
CN103494661B (en) * 2006-07-20 2016-03-30 奥巴斯尼茨医学公司 Can the polymeric medical device of bio-absorbable
US7846361B2 (en) 2006-07-20 2010-12-07 Orbusneich Medical, Inc. Bioabsorbable polymeric composition for a medical device
US8460364B2 (en) * 2006-07-20 2013-06-11 Orbusneich Medical, Inc. Bioabsorbable polymeric medical device
EP2073754A4 (en) * 2006-10-20 2012-09-26 Orbusneich Medical Inc Bioabsorbable polymeric composition and medical device background
US7959942B2 (en) * 2006-10-20 2011-06-14 Orbusneich Medical, Inc. Bioabsorbable medical device with coating
US20080099170A1 (en) * 2006-10-31 2008-05-01 The Procter & Gamble Company Process of making wet-microcontracted paper
DE102007015670A1 (en) * 2007-03-31 2008-10-02 Biotronik Vi Patent Ag Stent with radially expandable body
US20100093946A1 (en) * 2008-10-11 2010-04-15 Orbusneich Medical, Inc. Bioabsorbable Polymeric Compositions and Medical Devices
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
AU2008308474B2 (en) 2007-10-04 2014-07-24 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
JP2011504780A (en) * 2007-11-28 2011-02-17 ザ・プロヴォスト,フェローズ・アンド・スカラーズ・オブ・ザ・カレッジ・オブ・ザ・ホーリー・アンド・アンディヴァイデッド・トリニティー・オブ・クイーン・エリザベス,ニア・ダブリン Lumen prosthesis
US20090234429A1 (en) * 2008-02-07 2009-09-17 Lilip Lau Self-restraining endoluminal prosthesis
US20100057187A1 (en) * 2008-08-26 2010-03-04 Caldarise Salvatore G Intravascular stent having imrproved design for loading and deploying
WO2010027450A1 (en) * 2008-09-02 2010-03-11 Med Institute, Inc. Stent having less invasive ends and improved radial force
WO2010030928A1 (en) * 2008-09-15 2010-03-18 Abbott Laboratories Vascular Enterprises Limited Stent with independent stent rings and transitional attachments
US11298252B2 (en) 2008-09-25 2022-04-12 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
US8828071B2 (en) 2008-09-25 2014-09-09 Advanced Bifurcation Systems, Inc. Methods and systems for ostial stenting of a bifurcation
US8821562B2 (en) 2008-09-25 2014-09-02 Advanced Bifurcation Systems, Inc. Partially crimped stent
EP2344068B1 (en) 2008-09-25 2022-10-19 Advanced Bifurcation Systems Inc. Partially crimped stent
WO2010042854A1 (en) * 2008-10-10 2010-04-15 Orbusneich Medical, Inc. Bioabsorbable polymeric medical device
US20100292778A1 (en) * 2009-05-15 2010-11-18 Med Institute, Inc. Expandable stent comprising end members having an interlocking configuration
WO2010144325A1 (en) 2009-06-08 2010-12-16 Boston Scientific Scimed, Inc. Crosslinked bioabsorbable medical devices
KR101060607B1 (en) 2009-07-09 2011-08-31 전남대학교산학협력단 Method of manufacturing drug-releasing stent using titanium oxide thin film coating
US9649211B2 (en) 2009-11-04 2017-05-16 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US10092427B2 (en) 2009-11-04 2018-10-09 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
CA2794064A1 (en) 2010-03-24 2011-09-29 Advanced Bifurcation Systems, Inc. Methods and systems for treating a bifurcation with provisional side branch stenting
CA2794078A1 (en) 2010-03-24 2011-09-29 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
EP2549952A4 (en) 2010-03-24 2017-01-04 Advanced Bifurcation Systems, Inc. System and methods for treating a bifurcation
US9301864B2 (en) 2010-06-08 2016-04-05 Veniti, Inc. Bi-directional stent delivery system
US8864811B2 (en) 2010-06-08 2014-10-21 Veniti, Inc. Bi-directional stent delivery system
US9233014B2 (en) * 2010-09-24 2016-01-12 Veniti, Inc. Stent with support braces
KR101116673B1 (en) 2010-12-13 2012-02-22 전남대학교병원 Gene-releasing stent using titanium-oxide coated thin film and method for manufacturing thereof
CA2826760A1 (en) 2011-02-08 2012-08-16 Advanced Bifurcation Systems, Inc. Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
EP3449879B1 (en) 2011-02-08 2020-09-23 Advanced Bifurcation Systems Inc. System for treating a bifurcation with a fully crimped stent
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
EP2710984B1 (en) * 2012-09-19 2015-08-26 Biotronik AG Implant and system formed of a balloon catheter and implant
EP2799036A1 (en) 2013-04-02 2014-11-05 Biotronik AG Intraluminal endoprosthesis and method for production thereof
EP3457985B1 (en) * 2016-05-16 2021-02-17 Elixir Medical Corporation Uncaging stent
US11622872B2 (en) * 2016-05-16 2023-04-11 Elixir Medical Corporation Uncaging stent
US11638645B2 (en) * 2016-05-19 2023-05-02 University of Pittsburgh—of the Commonwealth System of Higher Education Biomimetic plywood motifs for bone tissue engineering
EP3664752A4 (en) * 2017-08-11 2021-03-10 Elixir Medical Corporation Uncaging stent
CN115501018A (en) * 2021-06-22 2022-12-23 微创神通医疗科技(上海)有限公司 Support and medicine-carrying support

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041126A (en) * 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
US5824059A (en) * 1997-08-05 1998-10-20 Wijay; Bandula Flexible stent
US5879370A (en) * 1994-02-25 1999-03-09 Fischell; Robert E. Stent having a multiplicity of undulating longitudinals
US5879381A (en) * 1996-03-10 1999-03-09 Terumo Kabushiki Kaisha Expandable stent for implanting in a body
US5911754A (en) * 1998-07-24 1999-06-15 Uni-Cath Inc. Flexible stent with effective strut and connector patterns
US6017365A (en) * 1997-05-20 2000-01-25 Jomed Implantate Gmbh Coronary stent
US6340366B2 (en) * 1998-12-08 2002-01-22 Bandula Wijay Stent with nested or overlapping rings
US6344053B1 (en) * 1993-12-22 2002-02-05 Medtronic Ave, Inc. Endovascular support device and method
US6375677B1 (en) * 1996-03-05 2002-04-23 Ewysio Medical Devices Inc. Expandable stent and method for delivery of same
US6375676B1 (en) * 1999-05-17 2002-04-23 Advanced Cardiovascular Systems, Inc. Self-expanding stent with enhanced delivery precision and stent delivery system
US6416539B1 (en) * 1997-06-30 2002-07-09 Medex, Inc. Controlled length intraluminal implant
US20020111671A1 (en) 2001-02-15 2002-08-15 Stenzel Eric B. Locking stent

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192307A (en) 1987-12-08 1993-03-09 Wall W Henry Angioplasty stent
CA2380683C (en) 1991-10-28 2006-08-08 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5938682A (en) 1996-01-26 1999-08-17 Cordis Corporation Axially flexible stent
US5868781A (en) 1996-10-22 1999-02-09 Scimed Life Systems, Inc. Locking stent
US5733330A (en) 1997-01-13 1998-03-31 Advanced Cardiovascular Systems, Inc. Balloon-expandable, crush-resistant locking stent
US5911732A (en) 1997-03-10 1999-06-15 Johnson & Johnson Interventional Systems, Co. Articulated expandable intraluminal stent
DE19728337A1 (en) 1997-07-03 1999-01-07 Inst Mikrotechnik Mainz Gmbh Implantable stent
US6156062A (en) 1997-12-03 2000-12-05 Ave Connaught Helically wrapped interlocking stent
US6129755A (en) 1998-01-09 2000-10-10 Nitinol Development Corporation Intravascular stent having an improved strut configuration
US6224626B1 (en) 1998-02-17 2001-05-01 Md3, Inc. Ultra-thin expandable stent
US6033436A (en) 1998-02-17 2000-03-07 Md3, Inc. Expandable stent
US6174316B1 (en) 1998-05-28 2001-01-16 Medtronic, Inc. Stent delivery system
US6083258A (en) 1998-05-28 2000-07-04 Yadav; Jay S. Locking stent
US6171334B1 (en) 1998-06-17 2001-01-09 Advanced Cardiovascular Systems, Inc. Expandable stent and method of use
US5997563A (en) * 1998-09-28 1999-12-07 Medtronic, Inc. Implantable stent having variable diameter
US6251134B1 (en) 1999-02-28 2001-06-26 Inflow Dynamics Inc. Stent with high longitudinal flexibility
US6409753B1 (en) 1999-10-26 2002-06-25 Scimed Life Systems, Inc. Flexible stent

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041126A (en) * 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
US6344053B1 (en) * 1993-12-22 2002-02-05 Medtronic Ave, Inc. Endovascular support device and method
US5879370A (en) * 1994-02-25 1999-03-09 Fischell; Robert E. Stent having a multiplicity of undulating longitudinals
US6375677B1 (en) * 1996-03-05 2002-04-23 Ewysio Medical Devices Inc. Expandable stent and method for delivery of same
US5879381A (en) * 1996-03-10 1999-03-09 Terumo Kabushiki Kaisha Expandable stent for implanting in a body
US6017365A (en) * 1997-05-20 2000-01-25 Jomed Implantate Gmbh Coronary stent
US6416539B1 (en) * 1997-06-30 2002-07-09 Medex, Inc. Controlled length intraluminal implant
US5824059A (en) * 1997-08-05 1998-10-20 Wijay; Bandula Flexible stent
US5911754A (en) * 1998-07-24 1999-06-15 Uni-Cath Inc. Flexible stent with effective strut and connector patterns
US6340366B2 (en) * 1998-12-08 2002-01-22 Bandula Wijay Stent with nested or overlapping rings
US6375676B1 (en) * 1999-05-17 2002-04-23 Advanced Cardiovascular Systems, Inc. Self-expanding stent with enhanced delivery precision and stent delivery system
US20020111671A1 (en) 2001-02-15 2002-08-15 Stenzel Eric B. Locking stent

Cited By (237)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030208263A1 (en) * 1994-05-19 2003-11-06 Burmeister Paul H. Tissue supporting devices
US20110184508A2 (en) * 1994-05-19 2011-07-28 Boston Scientific Scimed, Inc. Improved tissue supporting devices
US6669723B2 (en) * 1998-03-04 2003-12-30 Scimed Life Systems, Inc. Stent having variable properties and method of its use
US7402169B2 (en) * 1998-03-04 2008-07-22 Boston Scientific Scimed, Inc. Stent having variable properties and method of its use
US20060142849A1 (en) * 1998-03-04 2006-06-29 Killion Douglas P Stent having variable properties and method of its use
US7060091B2 (en) * 1998-03-04 2006-06-13 Boston Scientific Scimed, Inc. Stent having variable properties and method of its use
US7780719B2 (en) 1998-03-04 2010-08-24 Boston Scientific Scimed, Inc. Stent having variable properties and method of its use
US20100152836A1 (en) * 2000-03-06 2010-06-17 Boston Scientific Scimed, Inc. Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof
US8267991B2 (en) * 2000-03-06 2012-09-18 Boston Scientific Scimed, Inc. Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof
US8663317B2 (en) 2000-03-06 2014-03-04 Boston Scientific Scimed, Inc. Intraluminar perforated radially expandable drug delivery prosthesis and a method for the production thereof
US20050027351A1 (en) * 2001-05-14 2005-02-03 Cardiac Dimensions, Inc. A Washington Corporation Mitral valve regurgitation treatment device and method
US8257427B2 (en) 2001-09-11 2012-09-04 J.W. Medical Systems, Ltd. Expandable stent
US20090248137A1 (en) * 2001-09-11 2009-10-01 Xtent, Inc. Expandable stent
US7608102B2 (en) 2001-11-01 2009-10-27 Cardiac Dimensions, Inc. Focused compression mitral valve device and method
US8439971B2 (en) 2001-11-01 2013-05-14 Cardiac Dimensions, Inc. Adjustable height focal tissue deflector
US20100100175A1 (en) * 2001-11-01 2010-04-22 David Reuter Adjustable Height Focal Tissue Deflector
US20050021121A1 (en) * 2001-11-01 2005-01-27 Cardiac Dimensions, Inc., A Delaware Corporation Adjustable height focal tissue deflector
US7635387B2 (en) 2001-11-01 2009-12-22 Cardiac Dimensions, Inc. Adjustable height focal tissue deflector
US20040249452A1 (en) * 2001-11-01 2004-12-09 Adams John M. Focused compression mitral valve device and method
US9326876B2 (en) 2001-12-03 2016-05-03 J.W. Medical Systems Ltd. Apparatus and methods for delivery of multiple distributed stents
US8177831B2 (en) 2001-12-03 2012-05-15 Xtent, Inc. Stent delivery apparatus and method
US8083788B2 (en) 2001-12-03 2011-12-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US8574282B2 (en) 2001-12-03 2013-11-05 J.W. Medical Systems Ltd. Apparatus and methods for delivery of braided prostheses
US8702781B2 (en) 2001-12-03 2014-04-22 J.W. Medical Systems Ltd. Apparatus and methods for delivery of multiple distributed stents
US8956398B2 (en) 2001-12-03 2015-02-17 J.W. Medical Systems Ltd. Custom length stent apparatus
US20050272969A1 (en) * 2001-12-05 2005-12-08 Alferness Clifton A Device and method for modifying the shape of a body organ
US20040193260A1 (en) * 2001-12-05 2004-09-30 Alferness Clifton A. Anchor and pull mitral valve device and method
US20060142854A1 (en) * 2001-12-05 2006-06-29 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US7674287B2 (en) 2001-12-05 2010-03-09 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US7857846B2 (en) 2001-12-05 2010-12-28 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US8172898B2 (en) 2001-12-05 2012-05-08 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20050149182A1 (en) * 2001-12-05 2005-07-07 Alferness Clifton A. Anchor and pull mitral valve device and method
US20070055293A1 (en) * 2001-12-05 2007-03-08 Alferness Clifton A Device and method for modifying the shape of a body organ
US20070066879A1 (en) * 2002-01-30 2007-03-22 Mathis Mark L Body lumen shaping device with cardiac leads
US20080140191A1 (en) * 2002-01-30 2008-06-12 Cardiac Dimensions, Inc. Fixed Anchor and Pull Mitral Valve Device and Method
US9827099B2 (en) 2002-01-30 2017-11-28 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US9320600B2 (en) 2002-01-30 2016-04-26 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US20050209690A1 (en) * 2002-01-30 2005-09-22 Mathis Mark L Body lumen shaping device with cardiac leads
US9956076B2 (en) 2002-01-30 2018-05-01 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US9408695B2 (en) 2002-01-30 2016-08-09 Cardiac Dimensions Pty. Ltd. Fixed anchor and pull mitral valve device and method
US10206778B2 (en) 2002-01-30 2019-02-19 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US10327900B2 (en) 2002-01-30 2019-06-25 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US20110035000A1 (en) * 2002-01-30 2011-02-10 Cardiac Dimensions, Inc. Tissue Shaping Device
US8974525B2 (en) 2002-01-30 2015-03-10 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US9597186B2 (en) 2002-01-30 2017-03-21 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US20050216077A1 (en) * 2002-01-30 2005-09-29 Mathis Mark L Fixed length anchor and pull mitral valve device and method
US9827100B2 (en) 2002-01-30 2017-11-28 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US10052205B2 (en) 2002-01-30 2018-08-21 Cardiac Dimensions Pty. Ltd. Fixed anchor and pull mitral valve device and method
US9827098B2 (en) 2002-01-30 2017-11-28 Cardiac Dimensions Pty. Ltd. Fixed anchor and pull mitral valve device and method
US7828842B2 (en) 2002-01-30 2010-11-09 Cardiac Dimensions, Inc. Tissue shaping device
US20080319542A1 (en) * 2002-01-30 2008-12-25 Gregory Nieminen Tissue Shaping Device
US9474608B2 (en) 2002-05-08 2016-10-25 Cardiac Dimensions Pty. Ltd. Body lumen device anchor, device and assembly
US7452375B2 (en) 2002-05-08 2008-11-18 Cardiac Dimensions, Inc. Body lumen device anchor, device and assembly
US7828841B2 (en) 2002-05-08 2010-11-09 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20050187619A1 (en) * 2002-05-08 2005-08-25 Mathis Mark L. Body lumen device anchor, device and assembly
US10456257B2 (en) 2002-05-08 2019-10-29 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US20050149179A1 (en) * 2002-05-08 2005-07-07 Mathis Mark L. Body lumen device anchor, device and assembly
US10456258B2 (en) 2002-05-08 2019-10-29 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US20080097594A1 (en) * 2002-05-08 2008-04-24 Cardiac Dimensions, Inc. Device and Method for Modifying the Shape of a Body Organ
US20060173536A1 (en) * 2002-05-08 2006-08-03 Mathis Mark L Body lumen device anchor, device and assembly
US8062358B2 (en) 2002-05-08 2011-11-22 Cardiac Dimensions, Inc. Body lumen device anchor, device and assembly
US20070026132A1 (en) * 2002-11-15 2007-02-01 Williams Michael S Endoprostheses and methods of manufacture
US7704276B2 (en) * 2002-11-15 2010-04-27 Synecor, Llc Endoprostheses and methods of manufacture
US8075608B2 (en) 2002-12-05 2011-12-13 Cardiac Dimensions, Inc. Medical device delivery system
US20110066234A1 (en) * 2002-12-05 2011-03-17 Gordon Lucas S Percutaneous Mitral Valve Annuloplasty Delivery System
US20050119673A1 (en) * 2002-12-05 2005-06-02 Gordon Lucas S. Percutaneous mitral valve annuloplasty device delivery method
US20050096666A1 (en) * 2002-12-05 2005-05-05 Gordon Lucas S. Percutaneous mitral valve annuloplasty delivery system
US7837729B2 (en) 2002-12-05 2010-11-23 Cardiac Dimensions, Inc. Percutaneous mitral valve annuloplasty delivery system
US20080109059A1 (en) * 2002-12-05 2008-05-08 Cardiac Dimensions, Inc. Medical Device Delivery System
US8182529B2 (en) 2002-12-05 2012-05-22 Cardiac Dimensions, Inc. Percutaneous mitral valve annuloplasty device delivery method
US20060020335A1 (en) * 2002-12-26 2006-01-26 Leonard Kowalsky System and method to effect the mitral valve annulus of a heart
US7503931B2 (en) 2002-12-26 2009-03-17 Cardiac Dimensions, Inc. System and method to effect the mitral valve annulus of a heart
US8282680B2 (en) 2003-01-17 2012-10-09 J. W. Medical Systems Ltd. Multiple independent nested stent structures and methods for their preparation and deployment
US8740968B2 (en) 2003-01-17 2014-06-03 J.W. Medical Systems Ltd. Multiple independent nested stent structures and methods for their preparation and deployment
US20070135912A1 (en) * 2003-02-03 2007-06-14 Mathis Mark L Mitral valve device using conditioned shape memory alloy
US20100280602A1 (en) * 2003-02-03 2010-11-04 Cardiac Dimensions, Inc. Mitral Valve Device Using Conditioned Shape Memory Alloy
US7758639B2 (en) 2003-02-03 2010-07-20 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US20040158321A1 (en) * 2003-02-12 2004-08-12 Cardiac Dimensions, Inc. Method of implanting a mitral valve therapy device
US11452603B2 (en) 2003-05-02 2022-09-27 Cardiac Dimensions Pty. Ltd. Device and method for modifying the shape of a body organ
US20080015407A1 (en) * 2003-05-02 2008-01-17 Mathis Mark L Device and Method for Modifying the Shape of a Body Organ
US20040220657A1 (en) * 2003-05-02 2004-11-04 Cardiac Dimensions, Inc., A Washington Corporation Tissue shaping device with conformable anchors
US20080015679A1 (en) * 2003-05-02 2008-01-17 Mathis Mark L Device and Method for Modifying the Shape of a Body Organ
US11311380B2 (en) 2003-05-02 2022-04-26 Cardiac Dimensions Pty. Ltd. Device and method for modifying the shape of a body organ
US7887582B2 (en) 2003-06-05 2011-02-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20050010240A1 (en) * 2003-06-05 2005-01-13 Cardiac Dimensions Inc., A Washington Corporation Device and method for modifying the shape of a body organ
US8157855B2 (en) 2003-12-05 2012-04-17 Boston Scientific Scimed, Inc. Detachable segment stent
US20050125051A1 (en) * 2003-12-05 2005-06-09 Scimed Life Systems, Inc. Detachable segment stent
US20050137685A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc., A Washington Corporation Reduced length tissue shaping device
US7814635B2 (en) 2003-12-19 2010-10-19 Cardiac Dimensions, Inc. Method of making a tissue shaping device
US11318016B2 (en) 2003-12-19 2022-05-03 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US9956077B2 (en) 2003-12-19 2018-05-01 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US11109971B2 (en) 2003-12-19 2021-09-07 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US10166102B2 (en) 2003-12-19 2019-01-01 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US20060271174A1 (en) * 2003-12-19 2006-11-30 Gregory Nieminen Mitral Valve Annuloplasty Device with Wide Anchor
US10449048B2 (en) 2003-12-19 2019-10-22 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US7837728B2 (en) 2003-12-19 2010-11-23 Cardiac Dimensions, Inc. Reduced length tissue shaping device
US20050137450A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc., A Washington Corporation Tapered connector for tissue shaping device
US9526616B2 (en) 2003-12-19 2016-12-27 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US20050137451A1 (en) * 2003-12-19 2005-06-23 Cardiac Dimensions, Inc. A Washington Corporation Tissue shaping device with integral connector and crimp
US20060276891A1 (en) * 2003-12-19 2006-12-07 Gregory Nieminen Mitral Valve Annuloplasty Device with Twisted Anchor
US7794496B2 (en) 2003-12-19 2010-09-14 Cardiac Dimensions, Inc. Tissue shaping device with integral connector and crimp
US20060191121A1 (en) * 2003-12-19 2006-08-31 Lucas Gordon Tissue Shaping Device with Integral Connector and Crimp
US9566179B2 (en) 2003-12-23 2017-02-14 J.W. Medical Systems Ltd. Devices and methods for controlling and indicating the length of an interventional element
US8585747B2 (en) 2003-12-23 2013-11-19 J.W. Medical Systems Ltd. Devices and methods for controlling and indicating the length of an interventional element
US20050187606A1 (en) * 2004-02-20 2005-08-25 Scimed Life Systems, Inc. Stent with nested flexible connectors for flexibility and crimpability
US7479158B2 (en) 2004-02-20 2009-01-20 Boston Scientific Scimed, Inc. Stent with nested flexible connectors for flexibility and crimpability
US8460358B2 (en) 2004-03-30 2013-06-11 J.W. Medical Systems, Ltd. Rapid exchange interventional devices and methods
US20090234428A1 (en) * 2004-06-28 2009-09-17 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US9700448B2 (en) 2004-06-28 2017-07-11 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8986362B2 (en) 2004-06-28 2015-03-24 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8568469B1 (en) * 2004-06-28 2013-10-29 Advanced Cardiovascular Systems, Inc. Stent locking element and a method of securing a stent on a delivery system
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8470014B2 (en) 2004-08-25 2013-06-25 Advanced Cardiovascular Systems, Inc. Stent-catheter assembly with a releasable connection for stent retention
US9283099B2 (en) 2004-08-25 2016-03-15 Advanced Cardiovascular Systems, Inc. Stent-catheter assembly with a releasable connection for stent retention
US11033257B2 (en) 2005-01-20 2021-06-15 Cardiac Dimensions Pty. Ltd. Tissue shaping device
US20080215135A1 (en) * 2005-02-17 2008-09-04 Jacques Seguin Device Allowing the Treatment of Bodily Conduits at an Area of a Bifurcation
US9192492B2 (en) 2005-02-17 2015-11-24 Jacques Seguin Device allowing the treatment of bodily conduits at an area of a bifurcation
US8002818B2 (en) 2005-02-25 2011-08-23 Abbott Laboratories Vascular Enterprises Limited Modular vascular prosthesis having axially variable properties and improved flexibility and methods of use
US20090005848A1 (en) * 2005-02-25 2009-01-01 Abbott Laboratories Vascular Enterprises Limited Modular vascular prosthesis and methods of use
US8603154B2 (en) 2005-02-25 2013-12-10 Abbott Laboratories Vascular Enterprises Limited Modular vascular prosthesis and methods of use
US20060195175A1 (en) * 2005-02-25 2006-08-31 Abbott Laboratories Vascular Enterprises Limited Modular vascular prosthesis having axially variable properties and improved flexibility and methods of use
US8025694B2 (en) 2005-02-25 2011-09-27 Abbott Laboratories Vascular Enterprises Limited Modular vascular prosthesis and methods of use
US20070213810A1 (en) * 2005-03-14 2007-09-13 Richard Newhauser Segmented endoprosthesis
US7803180B2 (en) 2005-04-04 2010-09-28 Flexible Stenting Solutions, Inc. Flexible stent
US9592137B2 (en) 2005-04-04 2017-03-14 Flexible Stenting Solutions, Inc. Flexible stent
US20060271158A1 (en) * 2005-05-26 2006-11-30 Boston Scientific Scimed, Inc. Positional locking endoluminal device system
US20100256740A1 (en) * 2005-08-29 2010-10-07 Limon Timothy A Locking Polymer Stents
US9192494B2 (en) * 2005-08-29 2015-11-24 Advanced Cardiovascular Systems, Inc. Locking polymer stents
US8043366B2 (en) 2005-09-08 2011-10-25 Boston Scientific Scimed, Inc. Overlapping stent
US9883957B2 (en) 2006-03-20 2018-02-06 J.W. Medical Systems Ltd. Apparatus and methods for deployment of linked prosthetic segments
US8652198B2 (en) 2006-03-20 2014-02-18 J.W. Medical Systems Ltd. Apparatus and methods for deployment of linked prosthetic segments
US7503932B2 (en) 2006-04-11 2009-03-17 Cardiac Dimensions, Inc. Mitral valve annuloplasty device with vena cava anchor
US20070239270A1 (en) * 2006-04-11 2007-10-11 Mathis Mark L Mitral Valve Annuloplasty Device with Vena Cava Anchor
US8613698B2 (en) 2006-07-10 2013-12-24 Mcneil-Ppc, Inc. Resilient device
US8047980B2 (en) 2006-07-10 2011-11-01 Mcneil-Ppc, Inc. Method of treating urinary incontinence
US7892163B2 (en) 2006-07-10 2011-02-22 Mcneil-Ppc, Inc. Method of treating urinary incontinence
US20100218359A1 (en) * 2006-07-10 2010-09-02 Michelle Bartning Resilient device
US9173768B2 (en) 2006-07-10 2015-11-03 First Quality Hygienic, Inc. Resilient device
US9050183B2 (en) 2006-07-10 2015-06-09 First Quality Hygienic, Inc. Resilient device
US7717892B2 (en) 2006-07-10 2010-05-18 Mcneil-Ppc, Inc. Method of treating urinary incontinence
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
US20080009664A1 (en) * 2006-07-10 2008-01-10 Michelle Bartning Method of treating urinary incontinence
US20080009663A1 (en) * 2006-07-10 2008-01-10 Michelle Bartning Method of treating urinary incontinence
US20080009666A1 (en) * 2006-07-10 2008-01-10 Michelle Bartning Method of treating urinary incontinence
US8177706B2 (en) 2006-07-10 2012-05-15 Mcneil-Ppc, Inc. Method of treating urinary incontinence
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
US8608639B2 (en) 2006-07-10 2013-12-17 Mcneil-Ppc, Inc. Resilient device
US8753258B2 (en) 2006-07-10 2014-06-17 Mcneil-Ppc, Inc. Resilient device
US20080033230A1 (en) * 2006-07-10 2008-02-07 Michelle Bartning Resilient device
US11285005B2 (en) 2006-07-17 2022-03-29 Cardiac Dimensions Pty. Ltd. Mitral valve annuloplasty device with twisted anchor
US8070794B2 (en) 2007-01-09 2011-12-06 Stentys S.A.S. Frangible bridge structure for a stent, and stent including such bridge structures
US9457133B2 (en) 2007-02-20 2016-10-04 J.W. Medical Systems Ltd. Thermo-mechanically controlled implants and methods of use
US8980297B2 (en) 2007-02-20 2015-03-17 J.W. Medical Systems Ltd. Thermo-mechanically controlled implants and methods of use
US9339404B2 (en) 2007-03-22 2016-05-17 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8486132B2 (en) 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US20110130822A1 (en) * 2007-07-20 2011-06-02 Orbusneich Medical, Inc. Bioabsorbable Polymeric Compositions and Medical Devices
US8500794B2 (en) 2007-08-02 2013-08-06 Flexible Stenting Solutions, Inc. Flexible stent
US9101503B2 (en) 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
US20100030324A1 (en) * 2008-08-04 2010-02-04 Jacques Seguin Method for treating a body lumen
US9005274B2 (en) 2008-08-04 2015-04-14 Stentys Sas Method for treating a body lumen
US8006594B2 (en) 2008-08-11 2011-08-30 Cardiac Dimensions, Inc. Catheter cutting tool
US10010438B2 (en) 2008-10-06 2018-07-03 Flexible Stenting Solutions, Inc. Reconstrainable stent delivery system
US9149376B2 (en) 2008-10-06 2015-10-06 Cordis Corporation Reconstrainable stent delivery system
US8114149B2 (en) * 2009-10-20 2012-02-14 Svelte Medical Systems, Inc. Hybrid stent with helical connectors
US20110093059A1 (en) * 2009-10-20 2011-04-21 Svelte Medical Systems, Inc. Hybrid stent with helical connectors
US20110152604A1 (en) * 2009-12-23 2011-06-23 Hull Jr Raymond J Intravaginal incontinence device
US20110288622A1 (en) * 2010-05-18 2011-11-24 Abbott Cardiovascular Systems, Inc. Expandable endoprostheses, systems, and methods for treating a bifurcated lumen
US9402754B2 (en) * 2010-05-18 2016-08-02 Abbott Cardiovascular Systems, Inc. Expandable endoprostheses, systems, and methods for treating a bifurcated lumen
US9421098B2 (en) * 2010-12-23 2016-08-23 Twelve, Inc. System for mitral valve repair and replacement
AU2011349578A1 (en) * 2010-12-23 2013-07-11 Twelve, Inc. System for mitral valve repair and replacement
CN103491900A (en) * 2010-12-23 2014-01-01 第七铸造纽克公司 System for mitral valve repair and replacement
AU2016235012B2 (en) * 2010-12-23 2017-12-07 Twelve, Inc. System for mitral valve repair and replacement
AU2011349578B2 (en) * 2010-12-23 2016-06-30 Twelve, Inc. System for mitral valve repair and replacement
US9770331B2 (en) 2010-12-23 2017-09-26 Twelve, Inc. System for mitral valve repair and replacement
CN103491900B (en) * 2010-12-23 2017-03-01 托尔福公司 System for mitral valve repair and replacement
US10517725B2 (en) 2010-12-23 2019-12-31 Twelve, Inc. System for mitral valve repair and replacement
US11571303B2 (en) 2010-12-23 2023-02-07 Twelve, Inc. System for mitral valve repair and replacement
US20120165930A1 (en) * 2010-12-23 2012-06-28 The Foundy, Llc System for mitral valve repair and replacement
US9579196B2 (en) 2011-06-21 2017-02-28 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10751173B2 (en) 2011-06-21 2020-08-25 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9572662B2 (en) 2011-06-21 2017-02-21 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US11523900B2 (en) 2011-06-21 2022-12-13 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10034750B2 (en) 2011-06-21 2018-07-31 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10028827B2 (en) 2011-06-21 2018-07-24 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US11712334B2 (en) 2011-06-21 2023-08-01 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9585751B2 (en) 2011-06-21 2017-03-07 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9125740B2 (en) 2011-06-21 2015-09-08 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10945835B2 (en) 2011-10-19 2021-03-16 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10052204B2 (en) 2011-10-19 2018-08-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10335278B2 (en) 2011-10-19 2019-07-02 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11826249B2 (en) 2011-10-19 2023-11-28 Twelve, Inc. Devices, systems and methods for heart valve replacement
US9039757B2 (en) 2011-10-19 2015-05-26 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10299917B2 (en) 2011-10-19 2019-05-28 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11628063B2 (en) 2011-10-19 2023-04-18 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11617648B2 (en) 2011-10-19 2023-04-04 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9034032B2 (en) 2011-10-19 2015-05-19 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9295552B2 (en) 2011-10-19 2016-03-29 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11497603B2 (en) 2011-10-19 2022-11-15 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9034033B2 (en) 2011-10-19 2015-05-19 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US10702380B2 (en) 2011-10-19 2020-07-07 Twelve, Inc. Devices, systems and methods for heart valve replacement
US11202704B2 (en) 2011-10-19 2021-12-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11197758B2 (en) 2011-10-19 2021-12-14 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10299927B2 (en) 2011-10-19 2019-05-28 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9901443B2 (en) 2011-10-19 2018-02-27 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10016271B2 (en) 2011-10-19 2018-07-10 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11129714B2 (en) 2012-03-01 2021-09-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US10258468B2 (en) 2012-03-01 2019-04-16 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US11234821B2 (en) 2013-05-20 2022-02-01 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10111747B2 (en) 2013-05-20 2018-10-30 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10820996B2 (en) 2015-08-21 2020-11-03 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10238490B2 (en) 2015-08-21 2019-03-26 Twelve, Inc. Implant heart valve devices, mitral valve repair devices and associated systems and methods
US11576782B2 (en) 2015-08-21 2023-02-14 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10265172B2 (en) 2016-04-29 2019-04-23 Medtronic Vascular, Inc. Prosthetic heart valve devices with tethered anchors and associated systems and methods
US11033390B2 (en) 2016-04-29 2021-06-15 Medtronic Vascular, Inc. Prosthetic heart valve devices with tethered anchors and associated systems and methods
US11399939B2 (en) 2017-03-08 2022-08-02 Cardiac Dimensions Pty. Ltd. Methods and devices for reducing paravalvular leakage
US10390953B2 (en) 2017-03-08 2019-08-27 Cardiac Dimensions Pty. Ltd. Methods and devices for reducing paravalvular leakage
US10702378B2 (en) 2017-04-18 2020-07-07 Twelve, Inc. Prosthetic heart valve device and associated systems and methods
US10433961B2 (en) 2017-04-18 2019-10-08 Twelve, Inc. Delivery systems with tethers for prosthetic heart valve devices and associated methods
US11389295B2 (en) 2017-04-18 2022-07-19 Twelve, Inc. Delivery systems with tethers for prosthetic heart valve devices and associated methods
US10575950B2 (en) 2017-04-18 2020-03-03 Twelve, Inc. Hydraulic systems for delivering prosthetic heart valve devices and associated methods
US11737873B2 (en) 2017-04-18 2023-08-29 Twelve, Inc. Hydraulic systems for delivering prosthetic heart valve devices and associated methods
US11654021B2 (en) 2017-04-18 2023-05-23 Twelve, Inc. Prosthetic heart valve device and associated systems and methods
US10792151B2 (en) 2017-05-11 2020-10-06 Twelve, Inc. Delivery systems for delivering prosthetic heart valve devices and associated methods
US11786370B2 (en) 2017-05-11 2023-10-17 Twelve, Inc. Delivery systems for delivering prosthetic heart valve devices and associated methods
US10646338B2 (en) 2017-06-02 2020-05-12 Twelve, Inc. Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods
US11559398B2 (en) 2017-06-02 2023-01-24 Twelve, Inc. Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods
US10709591B2 (en) 2017-06-06 2020-07-14 Twelve, Inc. Crimping device and method for loading stents and prosthetic heart valves
US11464659B2 (en) 2017-06-06 2022-10-11 Twelve, Inc. Crimping device for loading stents and prosthetic heart valves
US11877926B2 (en) 2017-07-06 2024-01-23 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10786352B2 (en) 2017-07-06 2020-09-29 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10729541B2 (en) 2017-07-06 2020-08-04 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10603152B2 (en) 2017-08-31 2020-03-31 Kimberly-Clark Worldwide, Inc. Multi-component vaginal insert
US10603151B2 (en) 2018-08-27 2020-03-31 Kimberly-Clark Worldwide, Inc. Multi-component vaginal insert
US11596771B2 (en) 2020-12-14 2023-03-07 Cardiac Dimensions Pty. Ltd. Modular pre-loaded medical implants and delivery systems

Also Published As

Publication number Publication date
CA2389401C (en) 2009-09-15
KR20020093610A (en) 2002-12-16
DE60206694D1 (en) 2005-11-24
AU782122B2 (en) 2005-07-07
US6599314B2 (en) 2003-07-29
AU782122C (en) 2006-02-09
JP4233810B2 (en) 2009-03-04
EP1266638B1 (en) 2005-10-19
ATE306874T1 (en) 2005-11-15
EP1266638A2 (en) 2002-12-18
EP1266638A3 (en) 2003-03-19
DK1266638T3 (en) 2006-01-30
CA2389401A1 (en) 2002-12-08
KR100855889B1 (en) 2008-09-03
US20020188343A1 (en) 2002-12-12
ES2250587T3 (en) 2006-04-16
AU4065802A (en) 2002-12-12
JP2003047662A (en) 2003-02-18
DE60206694T2 (en) 2006-07-20
IL149646A0 (en) 2002-11-10
US20020188347A1 (en) 2002-12-12

Similar Documents

Publication Publication Date Title
US6562067B2 (en) Stent with interlocking elements
AU2004200611B2 (en) Locking stent
US6238409B1 (en) Articulated expandable intraluminal stent
US5902332A (en) Expandable intraluminal graft
CA1330186C (en) Expandable intraluminal graft
US7758634B2 (en) Bifurcated stent and delivery system
CA2497746C (en) Bifurcated stent
WO2001015632A1 (en) Stent design with end rings having enhanced strength and radiopacity
JP2002516704A (en) Deformable multicellular support stent
JP2007500579A (en) Vascular prosthesis
JP2004531347A (en) Highly flexible and flexible stent
US20200246165A1 (en) Expandable luminal stents and methods of use
JP2003159335A (en) Flexible stent
EP2088963B1 (en) Bifurcation stent design with over expansion capability
US20070078511A1 (en) Hybrid bifurcated stent

Legal Events

Date Code Title Description
AS Assignment

Owner name: CORDIS CORPORATION, FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MATHIS, MARK;REEL/FRAME:012417/0906

Effective date: 20011030

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: CARDINAL HEALTH SWITZERLAND 515 GMBH, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CORDIS CORPORATION;REEL/FRAME:042126/0259

Effective date: 20170329